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Summary of Main Points 
As in previous reports to avoid misinterpretation, it is vital at the outset to emphasise that: 
(i) information in this Report relates to those problem drug users who present for 
treatment rather than all those who have drug problems, or indeed all those who use 
drugs other than alcohol; 
(ii) like most health service data, the information is service dependent and the picture it 
provides of the extent and nature of drug problems will be influenced by drug 
service provision. 
Thus this Report should not be considered as portraying the total picture of drug use, but as 
providing a key element of that picture. The data would be particularly useful when considered in 
conjunction with results from any surveys or other research undertaken. 
MAIN POINTS 
• The number of cases, as distinct from persons, who were treated for problem drug misuse 
in the Greater Dublin Area in 1994 was 2,978; 
• The estimated number of persons treated for drug misuse was 2,702. 
• Almost eight out of ten cases of those attending treatment centres were male; 
• Most (92 per cent in 1994) were between the ages of 15 and 39 years; 
• Almost seven out of ten (67 per cent) lived with their family of origin; 
• Eighty-four per cent were unemployed; 
• One-third had left school before the official school leaving age of 15; 
• In 1994 twenty-seven per cent lived in the inner city; 
• In the majority of cases opiates (mainly heroin and morphine sulphate tablets) were the 
drugs which caused the most problems and for which clients sought treatment (82 per cent 
in 1994); 
• Sixty-nine per cent of the cases had injected their primary drug; 
• Of those who had ever injected their drugs, just over seven out of ten were currently 
injecting, but only 17 per cent were currently sharing injecting equipment; 
• Significant differences were observed between males and females on a number of 
variables. Females were less likely than males to be living in their families of origin; more 
likely to be living with a drug abusing partner than were the males and were found 
proportionately more likely to be sharing injecting equipment; 
• The number of persons who presented for treatment for the first time in 1994 was 1150. 
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CHAPTER 1 
Introduction 
This Report for the year 1994 is the fourth and last in the series of Reports on the Drug Treatment 
Reporting System in the Greater Dublin area published by the Health Research Board. The series 
commenced with the 1990 Report and the 1992 and 1993 Reports were combined last year. 
However, from the start of 1995, the data will be collected nationally and Reports from then on 
will cover the eight Health Board areas. 
Each one of the Reports in the series stands on its own and therefore there will be some repetition 
of: (a) the basic details of background to the reporting system and (b) description of the 
methodology and definitions used to enable the reader to have a complete picture within each 
Report. However, the fullest historical background to the setting up of the reporting system is 
contained in the 1990 Report (l) and we will just give some brief comments on the setting up of 
the drug treatment reporting system in this Report. 
The background to the collection of statistical and epidemiological data on treated drug misuse in 
Ireland included the initial participation in the Pompidou Group of the Council of Europe by the 
Health Research Board in 1984. The Pompidou Group of the Council of Europe is an 
epidemiological sub-group set up by the 6th Ministerial Conference of the Council of Europe in 
November 1981. The current work within this Pompidou group is embodied in the decision made 
at that conference which was to set up structures for: 
the development of administrative monitoring systems for the assessment of public health 
and social problems related to drug abuse. 
The work of the Pompidou Group is continually guided by directives from ministerial 
conferences and monitored by the permanent correspondents. These latter are usually senior civil 
servants, appointed by each of the participating member states to ensure the implementation of 
the work programme established by the ministers. The Pompidou Group maintains close contacts 
with other intergovernmental and non-governmental organisations concerned with problem drug 
use, such as the UNDCP and WHO. 
Administrative monitoring systems were initially put in place in 7 European cities including 
Dublin but these have been continually extended to other cities. These systems are based on 
information from a range of indicators of drug activity such as: 
(i) first treatment demand; 
(ii) hospital admissions; 
(iii) drug-related non-fatal emergencies; 
(iv) drug-related deaths; 
(v) persons charged for drug offences; 
(vi) imprisonment; 
(vii) seizures of illicit drugs; 
(viii) price/purity of illicit drugs; 
(ix) survey data; 
(x) drug-related AIDS cases. 
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Some indicators are better developed than others in the sense that definitive protocols have been 
put in place. The first treatment indicator, for instance, is the best developed. Data from the first 
treatment demand indicator serves two purposes – the first is indirect evidence of trends of drug 
misuse, that is, treated incidence. The second purpose of the first treatment demand indicator is 
as a direct indicator of the demand on services covered by the reporting system. This is the 
indicator involved in this Report. The establishment of an ongoing reporting system also enables 
socio-demographic information to be collected on first contacts, re-contacts and all contacts 
entering treatment in a given year. 
Reports on the data available on the indicators are prepared and sent to the Pompidou Group in 
Strasbourg. Co-ordinated reports are then formulated and interpretations of drug misuse in the 
various participating cities are thus provided and offer informed insights into similarities and 
differences between them. 
RATIONALE FOR THE REPORT 
The object or rationale for this report, as was that of previous reports, is to provide to the 
Department of Health and the treatment centres themselves ongoing information based on the 
data supplied to the Drug Section by the treatment centres to contribute in some way to an 
understanding of the epidemiology of treated drug misuse and to provide data useful to policy 
makers on the healthcare and social implications of drug misuse. No analyses in the form of 
research into underlying reasons for drug misuse are undertaken. The report takes the form of 
straightforward documentation of the data received. Because of the sensitive and confidential 
nature of the relationship between the drug misuser and the treatment centres, and the limitations 
on time available for completion of questionnaires, there are obvious constraints on the amount 
of information which can be gathered. 
METHODOLOGY 
There are three main categories into which the data fall: 
(a) Total Treatment Contacts – refers to the routine reporting of all clients receiving 
treatment during the year, including the Census data; 
(b) Census of Clients in Treatment – refers to clients in treatment in a residential centre 
on a particular day, i.e. 31 December prior to the year in question; and to non-
residential clients, those who received treatment at least once during the month of 
December, again prior to the appropriate year; 
(c) First Treatment Contacts – refers to a subset of clients who, during the year in 
question, entered treatment for the first time, never having had previous treatment 
anywhere for problem drug use. 
For each of these three categories, data will be analyzed on the basis of: 
(i) some socio-demographic characteristics; 
(ii) aspects of the client’s history of drug misuse; 
(iii) facets of the client’s injecting and needle-sharing practices. 
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The socio-demographic variables included for the purposes of this report are: age of client; sex of 
client; living status of client; employment status of client and finally education. The inclusion of 
and confinement to these particular socio-demographic variables is influenced by their being the 
most relevant and easily obtainable in the treatment reporting system of the Pompidou Group. 
 
The geographical area covered by the study is the Greater Dublin Area, comprising 
approximately 504km2 within the County of Dublin. This area encompasses Dublin County 
Borough, its north suburbs (Fingal part), its south suburbs (Belgard part) and also Dunlaoghaire 
County Borough and its suburbs. The total population of the area under study, according to the 
Ireland, Census of Population 1991, is 915,516 persons. 
This Report then is concerned with persons resident in the Greater Dublin Area who received 
treatment during 1994 at any one of the 15 centres participating in the reporting system. Between 
them they cover a range of services and facilities including both medical and non-medical care. 
Some of these centres are statutory bodies and some are voluntary. (Appendix C lists the centres 
and briefly describes the services they provide). The Satellite Clinics, that is clinics outside the 
inner city main clinics, were set up in 1992 and 1993. Baggot Street Clinic made returns in 1992 
and returns from Aisling and City Clinic commenced in 1993. As in the previous Reports, from 
our knowledge of service providers in the catchment area, it is felt that the centres who have 
returned data represent reasonable coverage of treated drug misuse. However, there are some 
gaps, as some centres were unable to send returns and also there is always the group of users who 
may not be included because they are receiving treatment from either general practitioners or 
agencies not participating in our reporting system. Population figures are noted in Appendix B. 
DEFINITIONS USED IN THIS REPORT 
DRUG MISUSE 
The working definition of drug misuse used in this Report is: 
The taking of a legal and/or illegal drug or drugs (excluding alcohol other than as a 
secondary drug of misuse, and tobacco) which harm the physical, mental or social well-
being of the individual, the group or society. 
DRUG TREATMENT 
The definition of treatment is: 
any activity which is targeted directly at people who have problems with their drug use 
and which aims to ameliorate the psychological, and medical or social state of individuals 
who seek help for their drug problems. This activity will often take place at specialised 
facilities for drug users, but may also take place in general services offering 
medical/psychological help to people with drug problems. 
Various therapies are used in the treatment of clients at the centres. These range from medical 
treatments, (such as detoxification, methadone programmes or drug-free programmes) to non-
medical therapies which can include addiction counselling, group therapy and psychotherapy. 
Therapies are generally provided by professionally qualified personnel, but some centres may 
deem certain persons, who are not professionally qualified, as suitable to undertake some of these 
therapies. Apart from the therapeutic centres, drug treatment may be  
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provided in hospitals, therapeutic communities, residential centres, out-patient clinics, street 
agencies, general practitioners and, of course, in the prisons. Under the definition of ‘treatment’ 
used in this report, information given over the telephone, or information solely concerned with 
queries about social welfare entitlements or benefits are not included as ‘treatment’. 
PRIMARY DRUG 
The primary drug is defined as the drug which, at the time of the current treatment contact, the 
client alleges is causing most problems and for which he or she has sought treatment. 
FREQUENCY OF USE 
This term refers to the number of times a person has used their primary drug within the 30 days 
prior to the completion of the questionnaire. 
SHARING 
As noted in previous reports, ‘sharing’ is a difficult concept to define since its practice is 
understood as quite different by different people. Sharing injecting equipment with a partner is 
often not regarded as ‘sharing’. Therefore it will be difficult to assess accurately the level of 
sharing of equipment. The treatment centres must take their clients’ accounts of their practices. 
DRUG FREE 
This term is used for those people who: 
− were recorded as ‘drug free’ in the previous month, although in receipt of 
methadone from the methadone maintenance programme; 
− were referred from prison where they had been drug free, or by a probation officer 
and who had stopped drug use in the remand period, or by Narcotics Anonymous; 
− sought counselling when drug free to avoid relapse. 
DATA COLLECTION 
For the year 1994, which is the subject of this Report, no information was received from eight of 
the treatment centres on the list in Appendix C 
A questionnaire (a copy of which is included in Appendix D) is completed by each of the 
treatment centres for each of their clients. This questionnaire had been used for the previous 
Reports so the data examined are similar for each of the years. In obtaining the cooperation of 
treatment centres, the objectives and the value of assembling and reporting on the data were 
discussed and assurances regarding the confidential nature of the data were given. No 
information from an individual participating centre would ever be divulged without the prior 
consent of that centre. No names appear on the questionnaires. Sealable plastic bags are provided 
to each treatment centre for return of completed questionnaires. The questionnaires are then 
checked and this, in some instances, involves clarification with particular treatment centres. 
Information used refers to cases, not to individuals in the Total Treatment section. Where First 
Treatment or Census data are concerned, these refer to individuals. This is necessary since a 
person could be receiving treatment from more than one centre and the anonymity of the system 
prevents determination of which clients are attending more than one centre. This introduces an 
element of double-counting and consequently an estimation of the rates for treated drug misuse is 
given in Appendix E. 
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Data were collected on the three previously mentioned categories. Data on Total Treatment 
contacts refer to all persons who received treatment for their problem drug misuse at any time 
during the calender year of 1994 and include the Census clients of the previous December. 
Where Census or Point Treated Prevalence is concerned the Census data refer to persons in 
treatment on a particular day or during a particular time period. This is rather similar to 
information from a census of the general population. Information from a census count is of 
interest because it is a count of the number of clients in treatment at a particular point in time. 
The profile of these clients tends to be different from that of other clients in treatment, for 
example. Census clients appear to be older and have been using their primary drug for a longer 
period of time. The third group of clients is the group of First Treatment Contacts or One-year 
Treated Incidence. Data on persons who entered treatment for the first time ever during 1994 are 
included under this heading. Over time first treatment data can point to changing patterns of more 
severe problematic drug use. New sub-populations of drug misusers who are coming into 
treatment for the first time can be identified from the usually older population of more chronic 
drug users who may repeatedly go in and out of treatment over periods of several years. 
CHAPTER DETAILS 
This first chapter has set out a brief description of the Reporting System and commented on the 
methodology and definitions used in the report. Chapter 2 will focus on Total Treatment clients, 
identifying and crosstabulating (a) some of the socio-demographic characteristics of these clients; 
(b) aspects of their history of drug misuse and (c) facets of their injecting and needle-sharing 
practices. Chapter 3 will treat the data on clients in treatment on a census date in a similar way to 
that of Chapter 2. Chapter 4 takes the first treatment clients into account and adopts a similar 
approach to the data as in the case of the other two groups. Chapter 5 looks at the data in graphic 
form for the three groups. A final chapter contains some concluding remarks on the general 
situation of drug misuse in the Greater Dublin area. 
Some variables from the data sheets, for example secondary drug misuse, are not included in the 
text and frequencies on these variables are given in Appendix A. 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
(1) O’Hare A and M.O’Brien: Treated Drug, Misuse in the Greater Dublin Area 1990. Dublin: The Health 
Research Board,1992. 
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CHAPTER 2 
Total Treatment Contacts 
The data examined in this chapter refer to all clients who received treatment during the year 
1994, as defined in Chapter 1. The tables are based on valid percentages but give the number of 
missing observations. Particular note should be taken that these figures relate to cases and not to 
persons. 
During 1994 the total number of clients who received treatment was 2,978. Sixty-one per cent 
were under 25 and 30 per cent were teenagers. The vast majority were males – 79 per cent. 
Irrespective of age, the proportion of males is at its highest 4.5 times higher than the proportion 
of females and at its lowest – in the 30-34 year age group – just over 2.5 times higher. Therefore 
numerically and proportionately far more males are in treatment than females. Sixty-seven per 
cent of all the clients were living with their family of origin and 84 per cent were unemployed. 
An opiate or opioid was the drug cited by the majority of clients as their primary drug of misuse. 
This was true in 1994 for over 80 per cent of the clients. The mean age of the clients in this total 
treatment group was 23.8 years – for males it was 23.7 and for females 24.4 years. 
The data for the year will now be dealt with under the headings: 
(a) some socio-demographic characteristics; 
(b) aspects of the history of drug misuse; 
(c) facets of injecting and needle-sharing practices. 
SECTION (A) – SOME SOCIO-DEMOGRAPHIC CHARACTERISTICS 
Under (a), the socio-demographic characteristics to be examined will be sex of client; age of 
client; living status, defined as with whom the client is living; age client left school; level of 
education achieved and employment status. 
In this section we will concentrate on cross-tabulation of the socio-demographic characteristics 
with sex and age since these cross-tabulations appear to yield the most important information. 
Tables 2.1 to 2.10 give these details. 
SEX 
Taking the variable sex first, we will look at sex by age, education, living status and employment 
status. This gives as broad a picture as is allowable from the data provided. 
AGE 
In the teenage group, which comprised 30 per cent of all clients, males were slightly younger 
than females (30 per cent males; 26 per cent females). As in previous reports the majority of 
clients in treatment were under 25 years old. The proportion of clients in treatment who were 
under 25 years old, both males and females, was 61 per cent, males being only slightly younger 
than females (62 per cent males; 56 per cent females) (Table 2.1) The difference between the 
sexes is significant at p<.009. 
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Table 2.1 – Age by Sex 
AGE                       MALES                     FEMALES                     TOTAL 
 per cent 
<15 years 1.8 1.8 1.8
15-19 years 28.6 24.3 27.7
20-24 years 31.8 29.8 31.4
25-29 years 19.4 22.3 20.0
30-34 years 11.5 16.2 12.5
35 years + 6.8 5.6 6.6
Per cent 100,0 100.0 100.0
N = 2332 605 2937*
*Missing Observations:41 
Chi-sq. = 15.2864 with 5 df. p<.009 
EDUCATION 
Up to 60 per cent of the clients had left school either before the official school-leaving age of 15 
years or at 15 (Table 2.2). However as Table 2.3 shows secondary level education was the level 
reached by over three-quarters of both male and female clients. The differences between males 
and females on these variables were not significant. 
Table 2.2 – Age Left School by Sex 
AGE LEFT SCHOOL                       MALES                      FEMALES                          TOTAL
 per cent 
<15 years 33.0 31.6 32.7
15 years 27.6 28.1 27.7
16 years 20.7 19.0 20.4
17 years+ 13.6 15.5 14.0
Still in Education 4.9 5.8 5.1
Never in Education 0.2 - 0.1
Per cent 100.0 100.0 100.0
N= 2174 548 2722*
*Missing observations= 256 
Chi-sq=3.96155 with 5df. p<.55 
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Table 2.3 – Highest Level of Education Reached by Sex 
LEVEL OF EDUCATION MALES FEMALES TOTAL 
 per cent 
Primary 17.3 14.0 16.7
Secondary 76.1 77.5 76.4
Third Level 1.4 2.4 1.6
Still in Education 4.9 6.0 5.1
Never in Education 0.2 – 0.2
Per cent 100.0 100.0 100.0
N= 2149 534 2683*
*Missing observations=295 
Chi-sq.=7.34690 with 4 df. p<.118 
LIVING STATUS 
By living status is meant with whom the client lived during 1994. The continuing dominance of 
the proportion of clients living with their family of origin is noteworthy. Also of note are the 
significant differences between the sexes on this variable. While almost half of females have 
continued to live with their family of origin, over 7 out of 10 males have done so. And more than 
a quarter of females live with a drug-using partner in contrast to a mere six per cent of males. 
Table 2.4 – Living Status by Sex 
LIVING STATUS MALES FEMALES TOTAL 
 per cent 
Alone 4.7 10.2 5.9
Family of origin 72.0 48.9 67.3
Partner drug user 5.5 26.0 9.7
Partner non-drug user 9.9 4.7 8.9
Institution/Homeless 2.4 2.6 2.5
Other 5.4 7.6 5.8
Per cent 100.0 100.0 100.0
N= 2236 577 2813*
*Missing observations=165 
Chi-sq=275.29300 with 5df. p<000 
EMPLOYMENT STATUS 
The over-representativeness of the unemployed among the clients is again evidenced by the 
proportions of both men and women who are unemployed among the clients – a level of 84 per 
cent overall and only a slightly higher level for men than for women – 84 per cent for men;  
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employment with a further 5 per cent being students. For women, the proportion of employed 
was seven per cent, but a further six per cent were housewives and 5 per cent were students. 
Table 2.5 – Employment Status by Sex 
EMPLOYMENT STATUS MALES FEMALES TOTAL 
 per cent 
Unemployed 84.3 81.5 83.7
Employed 10.6 6.9 9.8
Student 4.8 5.4 4.9
Housewife - 6.2 1.3
Other 0.3 - 0.2
Per cent 100.0 100.0 100.0
N= 2315 612 2927*
*Missing observations = 51 
Chi-sq 153.22421 with 4df. p<-000 
Summing up on the variable sex, it may be seen that while a much higher proportion of clients 
are men, there are few differences between the sexes on the socio-demographic variables – both  
males and females have well over half in the under 25 year age groups; both have similar school-
leaving ages and levels of achieved education and both have over 80 per cent unemployment 
levels. The only area where differences occur is in the living status of the clients – women being 
far less likely to live with their family of origin than are males and much more likely to live with 
a drug-using partner. We are unable to even guess at the underlying reasons for these significant 
differences and this is an area needing some in-depth research to explain. We have shown that the 
mean age of females is greater than that of males, but it would not appear to be at such a level as 
to explain the differences. 
AGE 
Turning now to the variable age, we look first at sex by age. The imbalance in the proportions of 
males and females in the age groups may be seen in Table 2.6. The highest proportion of females 
is in the 30-34 year age group (27 per cent). 
Table 2.6 – Sex by Age 
<15 15-19 20-24 25-29 30-34 35+ Total SEX 
per cent 
Males 79.6 82.0 80.5 77.0 73.3 82.4 79.4
Females 20.4 18.0 19.5 23.0 26.7 17.6 20.6
Per cent 100.0 100.0 100.0 100.0 100.0 100.0 100.0
N = 54 815 921 587 367 193 2937*
*Missing observations = 41 
Chi-sq=15.28646 with 5 df. p<.009 
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EDUCATION 
We had remarked in earlier reports on the improving levels of participation in education and the 
likelihood that the older the client, the more likely he or she would be to have left school before 
the official school-leaving age. This continued to be evident in the 1994 figures. (Tables 2.7 and 
2.8) 
Table 2.7 – Age Left School by Age 
<15 15-19 20-24 25-29 30-34 35+ Total AGE LEFT SCHOOL 
per cent 
<15 years 15.4 30.8 26.0 37.3 39.9 52.1 32.8
15 years – 28.7 30.7 30.3 25.6 12.3 27.8
16 years – 20.7 25.4 18.3 17.7 12.9 20.5
17 years+ – 9.9 16.9 13.6 15.9 21.5 14.0
Still in Education 84.6 9.9 1.0 0.6 0.3 – 4.9
Never in Education – – – – 0.6 1.2 0.1
Per cent 100.0 100.0 100.0 100.0 100.0 100.0 100.0
N= 52 791 870 531 328 163 2735*
*Missing observations=243 
Chi-sq=934.53685 with 25df. p<000 
 
 
Table 2.8 – Highest Level of Education Reached by Age 
<15 15-19 20-24 25-29 30-34 35+ Total LEVEL OF EDUCATION 
per cent 
Primary 4.0 13.1 12.1 19.2 26.9 31.3  16.67 
Secondary 8.0 76.2 85.9 79.0 67.2 62.0 6.5
Third level – 0.6 0.9 1.2 5.0 4.9 1.6
Still in Education 88.0 10.0 1.1 0.6 0.3 – 5.0
Never in Education – – – – 0.6 1.8 0.2
Per cent 100.0 100.0 100.0 100.0 100.0 100.0 100.0
N= 50 777 849 520 338 163 2697*
*Missing observations=281 
Chi-sq=975.61957 with 20df. p<000 
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LIVING STATUS 
We commented earlier on the lower proportion of women living with their family of origin. Since 
we have seen that the mean age of females is older than that of males, it may be surmised and 
indeed is only to be expected, the older the client the less likely he or she is to be living with their 
family of origin. 
Table 2.9 – Living Status by Age 
<15 15-19 20-24 25-29 30-34 35+ Total LIVING STATUS 
per cent 
Alone – 1.2 4.6 7.1 10.9 21.6 5.8
Family of origin 88.9 86.9 73.3 54.9 41.1 31.0 67.4
Partner drug user – 1.7 8.2 15.5 20.5 18.1 9.9
Partner non-drug user – 0.4 6.7 16.2 18.2 19.3 8.8
Institution/Homeless 7.4 3.7 0.8 2.0 3.5 2.9 2.4
Other 3.7 6.0 6.3 4.4 5.9 6.4 5.7
Per cent 100.0 100.0 100.0 100.0 100.0 100.0 100.0
N= 54 803 889 563 341 171 2821*
*Missing observations =157 
Chi-sq=581.98719 with 25df. p<.000 
EMPLOYMENT STATUS 
From 15 years old onwards the level of unemployment has been over 80 per cent for all age 
groups. Although the official school leaving age is 15 years old, some seven clients aged under 
15 were recorded as being unemployed and a further one as being employed. Obviously the vast 
majority of this age group would be, and are, still at school. 
Table 2.10 – Employment Status by Age 
<15 15-19 20-24 25-29 30-34 35+ Total EMPLOYMENT STATUS 
per cent 
Unemployed 13.2 81.8 88.6 86.1 81.4 88.5 83.9
Employed 1.9 8.3 9.1 11.4 13.7 9.4 9.8
Student 84.9 9.6 1.2 0.7 0.3 0.5 4.8
Housewife – – 1.0 1.7 4.4 1.0 1.3
Other – 0.4 0.1 0.2 0.3 0.5 0.2
Per cent 100.0 100.0 100.0 100.0 100.0 100.0 100.0
N= 53 822 913 589 365 192 2934*
*Missing observations = 44 
Chi-sq=906.93247 with 20df. p<.000 
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 SECTION (b) – ASPECTS OF THE CLIENTS’ HISTORY OF DRUG MISUSE 
PRIMARY DRUG OF MISUSE 
Having considered some socio-demographic characteristics of the clients in this prevalence 
group, we now turn our attention to the record of drug misuse by those same clients. The term 
‘primary drug’ is used for the drug which caused the most problems and for which treatment was 
sought. 
We will now look first at some cross-tabulations of sex and age with various aspects of the 
primary drug of misuse and then examine primary drug, frequency of use, route of administration 
and age first used primary drug crosstabulating them with each other. We will first look at the 
variable sex. 
SEX 
Table 2.11 shows that whether the client is male or female, for over eighty per cent of the clients 
an opiate or opioid was the primary drug of misuse. The only other proportion which was in 
double figures was that 11 per cent of males had cannabis as their primary drug of misuse. 
Table 2.11 – Primary Drug of Misuse by Sex 
PRIMARY DRUG MALES FEMALES TOTAL 
 per cent 
Opiates/Opioids  81.6 84.3 82.3
Hypnotics/Sedatives  1.7 2.0 1.8
Hallucinogens  4.0 4.9 4.2
Volatile Inhalants  0.7 1.1 0.8
Cannabis  11.2 5.7 10.1
Others  0.8 1.5 0.9
Per cent  100.0 100.0 100.0
N=  2336 610 2946*
*Missing observations=32 
Chi-sq=20.11251 with 5df. p<.001 
AGE 
In examining age by primary drug we will first consider the mean age of the clients by primary 
drug of misuse. These are as follows: 
Opiates/Opioids 24.5 years N=2331 
Stimulants 24.8 years N=20 
Hypnotics/Sedatives 28.3 years N=44 
Hallucinogens 19.4 years N=117 
Volatile Inhalants 14.4 years N=22 
Cannabis 20.0 years N=276 
Other drugs 15.5 years N=6 
All drugs 23.8 years N=2816 
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As may be seen from the mean age of the clients by the drug of misuse, there are few differences 
between those using opiates or an opioid or stimulants – their mean ages are 25 years old. It 
could be anticipated that the mean age of users of volatile inhalants would be very young. 
Cannabis users are also mainly among the younger users. 
Looking at the more detailed age groups there is confirmation of the information on the mean age 
of the clients by primary drug of misuse being different with age. However, most significant 
differences occurred between the under 15s and the other age groups. For instance, where 
opiates/opioids were concerned the proportion in the under 15 year olds was 8 per cent, it was 70 
per cent for the 15-19 year olds and rose as high as 92 per cent for the 30-34 year olds. Regarding 
cannabis, where 47 per cent of the under 15 year olds cited cannabis as their primary drug of 
misuse, only 19 per cent of the 15-19 year olds did and the proportions decreased dramatically in 
the other age groups as well. (Table 2.12). 
Table 2.12 – Primary Drug of Misuse by Age 
< l5 15-19 20-24 25-29 30-34 35+ TOTAL PRIMARY DRUG 
   per cent    
Opiates/Opioids 7.5 69.8 87.4 90.7 92.4 86.5 82.3
Hypnotics/Sedatives 3.8 1.3 0.8 1.5 2.5 7.3 1.8
Hallucinogens 13.2 4.1 1.5 0.5 4.2
Volatile Inhalants 26.4 8.4 – – – – 0.7
Cannabis 47.2 18.9 6.8 5.4 4.1 4.7 10.1
Other 1.9 0.7 1.0 0.8 1.1 1.0 0.9
Per cent 100.0 100.0 100.0 100.0 100.0 100.0 100.0
N= 53 822 926 593 367 192 2953*
*Missing observations=25 
Chi-sq=867.09887 with 25df. p<.000 
When we pursue the primary drug variable further (Tables 2.13 and 2.13A) and look at age first 
used, the age differences are again pointed up. We have inserted this information both ways – 
primary drug by age primary drug first used/age primary drug first used by age – to further 
support the evidence of the importance of age difference in the misuse of different drugs. 
Table 2.13 – Primary Drug by Age Primary Drug First Used 
<15 15-19 20-24 25+ TOTAL PRIMARY DRUG 
 per cent    
Opiates/Opioids 45.0 84.9 92.0 90.5 82.5
Hypnotics/Sedatives 4.7 1.0 1.3 3.1 1.6
Hallucinogens 8.8 4.2 2.9 0.8 4.1
Volatile Inhalants 6.6 0.1 - - 0.8
Cannabis 34.4 9.2 2.6 3.4 10.1
Other 0.6 0.7 1.1 2.3 0.9
Per cent 100.0 100.0 100.0 100.0 100.0
N= 320 1660 612 262 2854*
*Missing observations= 124 
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Table 2.13A – Age Primary Drug first Used by Primary Drug 
OP./OP. HY/S. HALL. VOL. IN. CANN. OTHER TOTAL AGE FIRST USED 
   per cent    
<15 years 6.1 31.9 23.9 95.5 38.2 7.7 11.2
15-19 years 59.9 34.0 59.0 4.5 53.1 42.3 58.2
20-24 years 23.9 17.0 15.4 – 5.6 26.9 21.4
25 years + 10.1 17.0 1.7 – 3.1 23.1 9.2
Per cent 100.0 100.0 100.0 100.0 100.0 100.0 100.0
N= 2354 47 117 22 288 26 2854*
*Missing observations = 124 
Chi-sq=514.47885 with 15df. p<000 
AGE PRIMARY DRUG FIRST USED BY SEX AND AGE 
We examined the data to see whether or not there was a difference between males and females in 
the age at which they had first used their primary drug. Overall, up to 20 years old, males were 
significantly younger than females when they first used. (p<.000). 
Table 2.14 – Age Primary Drug First Used by Sex 
MALES FEMALES TOTAL AGE FIRST USED 
 per cent  
< 15 years 10.7 13.9 11.3
15-19 years 60.0 50.2 58.0
20-24 years 20.7 24.4 21.5
25 years+ 8.6 11.5 9.2
Per cent 100.0 100.0 100.0
N= 2253 582 2835*
*Missing observations = 143 
Chi-sq=19.20288 with 3df. p<000 
 
Table 2.15 – Age First Used Primary Drug by Age 
AGE FIRST USED <15 15-19 20-24 25-29 30-34 35+ TOTAL 
    per cent    
<15 years 100.0 16.6 4.2 10.7 6.6 6.3 11.3
15-19 years – 83.4 67.4 37.3 35.1 26.4 58.1
20-24 years – – 28.4 38.4 26.9 24.7 21.4
25 years+ – – – 13.7 31.4 42.5 9.2
Per cent 100.0 100.0 100.0 100.0 100.0 100.0 100.0
N= 54 805 895 571 350 174 2849*
*Missing observations =129 Chi-sq=1543.67407 with 15df. p<.000 
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DURATION OF USE OF PRIMARY DRUG 
Considering the actual duration of use of the primary drug by all the clients, significant 
differences appeared between duration of use of particular drugs and the length of time they had 
been used. Volatile inhalants had the shortest duration of use before the client came into 
treatment – 91 per cent of the misuse having been for two years or less. At the other end of the 
time spectrum, and one must keep in mind the small numbers, 66 per cent of the hypnotics and 
sedatives misuse had been going on for more than five years. 
Table 2.16 – Duration of Use of Primary Drug by Primary Drug 
OP./OP. HYP/SED HALLUC. VOL. IN. CANNB. OTHER TOTAL DURATION OF USE 
   per cent    
<1 year 2.6 4.5 13.7 27.5 6.9 23.1 3.9
1-2 years 39.4 25.0 53.8 63.6 40.2 42.3 40.1
3-4 years 21.8 4.5 23.1 9.1 19.2 19.2 21.2
5-9 years 16.6 29.5 8.5 – 23.2 15.4 17.0
10 years+ 19.5 36.4 0.9 – 10.5 – 17.8
Per cent 100.0 100.0 100.0 100.0 100.0 100.0 100.0
N= 2331 44 117 22 276 26 2816*
*Missing observations=162 
Chi-sq=187.02069 with 20df. p<.000 
DURATION OF USE AND FREQUENCY OF USE OF PRIMARY DRUG BY SEX AND AGE 
Considering sex differences on this variable of duration of use of primary drug, the differences 
are significant at the p<.009 level. Females had a proportionately higher likelihood of having 
used for less than a year or more than 5 years than had males. This is borne out by Table 2.17. 
Table 2.17 – Duration of use of Primary Drug by Sex 
MALES FEMALES TOTAL DURATION OF USE 
 per cent  
<1 year 3.3 6.3 3.9
1-2 years 40.8 37.6 40.2
3-4 years 21.8 19.3 21.3
5-9 years 16.6 17.8 16.8
10 years+ 17.5- 19.0 17.8
Per cent 100.0 100.0 100.0
N= 2223 574 2797*
*Missing observations=181 
Chi-sq=13.39520 with 4df. p<.009 
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On the frequency of use of primary drug by sex there was a high level of use as the majority of 
both males and females used their primary drug daily or more often – 72 per cent of males and 70 
per cent of females. Women were slightly more likely to be drug free or use less than once 
weekly. 
Table 2.18 Frequency of Use of Primary Drug by Sex 
MALE FEMALE TOTAL FREQUENCY IN PAST 
MONTH  per cent  
Drug free 10.3 12.1 10.7
Less than once weekly 3.4 7.7 4.3
Once weekly 3.0 2.4 2.8
Twice weekly 11.5 8.1 10.8
Daily 49.5 41.4 47.8
Twice or more daily 22.4 28.3 23.6
Per cent 100.0 100.0 100.0
N= 2304 594 2898*
*Missing observations=80 
Chi-sq=41.33552 with 5df. p<.000 
That duration of misuse would be related to age, in that the older the client the more likely they 
were to have been misusing for a longer period, is hardly surprising and Tables 2.19 and 2.19A 
gives the details. 
Table 2.19 – Duration of Use of Primary Drug by Age 
<15 15-19 20-24 25-29 30-34 35+ TOTAL DURATION 
   per cent    
<1 year 32.7 6.4 3.0 1.3 2.0 0.6 3.9
1-2 years 61.2 72.0 41.2 18.1 12.6 9.1 40.1
3-4 years 2.0 17.7 34.1 19.7 9.6 6.8 21.3
5-9 years 4.1 3.3 20.1 30.6 21.3 13.6 16.9
10 years + – 0.6 1.6 30.4 54.4 69.9 17.7
Per cent 100.0 100.0 100.0 100.0 100.0 100.0 100.0
N= 49 793 889 559 342 176 2808*
*Missing observations = 170 
Chi-sq=1652.62297 with 20df. p<-000 
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Table 2.19A – Age by Duration of Use of Primary Drug 
AGE <l yr 1-2 yrs 3-4 yrs 5-9 yrs 10 yrs+ TOTAL 
 per cent 
<15 years 14.7 2.7 0.2 0.4 – 1.7
15-19 years 46.8 50.7 0.2 5.5 1.0 28.2
20-24 years 24.8 32.5 23.4 37.7 2.8 31.7
25-29 years 6.4 9.0 50.6 36.0 34.1 19.9
30-34 years 6.4 3.8 18.4 15.4 37.3 12.2
35 years+ 0.9 1.4 5.5 5.1 24.7 6.3
Per cent 100.0 100.0 100.0 100.0 100.0 100.0
N= 109 1127 599 475 498 2808
*Missing observations = 170 
AGE BY FREQUENCY OF USE OF PRIMARY DRUG 
It might reasonably be assumed that the younger the client the less frequent would be the use of 
their primary drug and this indeed was the case where the under 15 year olds were concerned. 
However, where 57 per cent of the under 15s were drug free or used less than once weekly this 
changed completely for the 15-19 year olds where only 14 per cent were in the same categories 
but 62 per cent were using daily or more often in contrast to 7 per cent of the under 15s. (Table 
2.20) 
Table 2.20 – Frequency of Use of Primary Drug by Age 
<15 15-19 20-24 25-29 30-34 35+ TOTALFREQUENCY OF USE 
IN PAST MONTH    per cent    
Drug free 26.4 9.6 10.6 10.3 10.6 12.5 10.7
Less than once weekly 30.2 4.7 3.5 3.1 3.9 3.3 4.3
Once weekly 13.2 5.3 1.9 1.4 1.1 2.2 2.9
Twice weekly 22.6 18.5 9.2 5.2 5.0 9.2 10.7
Daily 5.7 51.8 52.8 44.2 40.1 44.6 47.9
Twice or more daily 1.9 10.2 22.0 35.8 39.3 28.3 23.6
Per cent 100.0 100.0 100.0 100.0 100.0 100.0 100.0
N= 53 815 914 581 359 184 2906*
*Missing observations=72 
Chi-sq=417.00227 with 25df. p<.000 
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FREQUENCY OF USE BY THE ROUTE OF ADMINISTRATION 
As could be predicted the injectors misused their primary drug far more frequently than the other 
misusers – 83 per cent misusing daily or more often. This is in contrast to 57 per cent of smokers 
misusing daily or more often and also more than half (54 per cent) of those who ate or drank their 
primary drug. 
Table 2.21 – Frequency of Use by Route of Administration of Primary Drug 
FREQUENCY OF USE 
IN PAST MONTH 
INJECT SMOKE  EAT/DRINK SNIFF  TOTAL 
per cent 
Drug-free 7.0 11.6 15.0 29.0 9.5
Less than once weekly 2.2 7.8 5.8 16.1 4.3
Once weekly 0.8 5.3 7.2 12.9 2.9
Twice weekly 6.6 17.7 17.0 19.4 10.9
Daily 51.7 45.3 40.9 22.6 48.4
Twice or more daily 31.5 12.2 13.9 – 24.0
Per cent 100.0 100.0 100.0 100.0 100.0
N= 1745 739 359 31 2874*
*Missing observations=104 
Chi-sq=360.48780 with 15df. p<.000 
ROUTE OF ADMINISTRATION BY PRIMARY DRUG 
Of those who cited an opiate or opioid as their primary drug 73 per cent injected and 19 per cent 
smoked. As might be expected 99 per cent of cannabis misusers smoked that drug and the results 
on the other types of drugs were also predictable. 
Table 2.22 – Route of Administration of Primary Drug by Primary Drug 
OP/OP. HY/SED HALL. VOL.IN. CANN. OTHERS TOTAL ROUTE OF 
ADMINISTRATION    per cent    
Inject 73.3 5.9 – – 0.3 8.0 60.5
Smoke 18.5 3.9 5.7 8.7 98.6 20.0 25.8
Eat/Drink 8.1 90.2 92.7 - 0.7 48.0 12.6
Sniff 0.1 - 1.6 91.3 0.3 24.0 1.1
Per cent 100.0 100.0 100.0 100.0 100.0 100.0 100.0
N= 2396 51 123 23 296 25 2914*
*Missing observations=64 
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SEX 
We then considered the route by which men and women administered his or her primary drug and 
no significant differences were apparent here. The majority of both males and females injected 
their primary drug (60 per cent males and 61 per cent females). Since the majority of clients had 
cited their primary drug as an opiate, this is not a surprising finding. 
Table 2.23 Route of Administration of Primary Drug by Sex 
MALE FEMALE TOTAL ROUTE OF 
ADMINISTRATION  per cent  
Inject 60.2 61.4 60.4
Smoke 26.7 22.6 25.8
Eat/Drink 12.1 14.5 12.6
Sniff 1.0 1.5 1.1
Per cent 100.0 100.0 100.0
N= 2296 594 2890*
*Missing observations=88 Chi-sq=6.48005 with 3df. p<.09 
AGE 
The route of administration of primary drug by age again shows the dramatic difference between 
the under 15s and those in the older age groups. The jump in the proportion of injectors in the 
under 15s from 2 per cent to 44 per cent of the 15-19 year olds has followed the same pattern as 
in other years. Thus injecting becomes the most used route of administration of the primary drug 
of misuse from 15 years old onwards. 
Table 2.24 – Route of Administration of Primary Drug by Age 
<15 15-19 20-24 25-29 30-34 35+ TOTAL ROUTE OT 
ADMINISTRATION    per cent    
Inject 1.9 43.7 63.8 76.2 72.1 64.6 60.5
Smoke 60.4 40.1 25.3 13.4 14.1 16.0 25.8
Eat/drink 15.1 14.9 10.6 10.1 13.0 19.3 12.6
Sniff 22.6 1.2 0.3 0.3 0.8 – 1.0
Per cent 100.0 100.0 100.0 100.0 100.0 100.0 100.0
N= 53 817 916 575 355 181 2897*
*Missing observations=81 
Chi-sq=515.89199 with 15df. p<.000 
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Table 2.24A Age by Route of Administration of Primary Drug 
INJECT SMOKE EAT/DRINK SNBPP TOTAL AGE 
  per cent   
<15 years 0.1 4.3 2.2 40,0 1.8
15-19 years 20.4 43.9 33.3 33.3 28.0
20-24 years 33.3 31.0 26.5 10.0 31.6
25-29 years 25.0 10.3 15.8 6.7 19.9
30-34 years 14.6 6.7 12.6 10.0 12.3
35 years+ 6.7 3.9 9.6 - 6.2
Per cent 100.0 100.0 100.0 100.0 100.0
N= 1753 748 366 30 2897*
*Missing observations=81 
SECTION (C) – FACETS OF INJECTING AND NEEDLE SHARING PRACTICES 
We will now turn to a particular group within the overall group of clients presenting for treatment 
during 1994 and that is the high-risk group – those who had ever injected their primary drug. This 
group is of special interest since injection of drugs is regarded as the most risk-prone form of 
misuse, given its association with infection, in particular HIV and consequent serious damage to 
health. Of those who had ever injected, that is 2,050 or 79 per cent of the total number of clients, 
the proportion currently injecting is 71 per cent or 1,408 clients. There are some 63 clients on 
whom there is no information as to whether currently injecting or not. The crosstabulations to be 
examined on this group will be – clients who are currently injecting by sex and age and by 
whether they are currently injecting or not. Then the sex and age of clients will be crosstabulated 
by whether they are currently sharing or not. 
CURRENTLY INJECTING BY SEX 
We first look at the sex breakdown of clients who had ever injected and were currently injecting. 
Almost identical proportions of men and women who had ever injected were currently injecting – 
71 per cent of both. 
Table 2.25 – Currently Injecting by Sex 
MALES FEMALES TOTAL CURRENTLY INJECTING 
 per cent  
Yes 70.7 71. 4 70.9
No 29.3 28.6 29.1
Per cent 100.0 100.0 100.0
N= 1553 434 1987*
*Missing observations=63 
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CURRENTLY INJECTING BY AGE 
Considering the age of those who had ever injected and were currently injecting, as we had been 
noting earlier in Table 2.24 while the route of the primary drug of misuse may have been 
injecting for one client in the under 15 year olds in the past, that was the person currently 
injecting in that age group. This one case was in contrast to the proportion of those who had ever 
injected in the 15-19 year age group and were now currently injecting – 73 per cent. 
Table 2.26 – Currently Injecting by Age 
15-19 20-24 25-29 CURRENTLY INJECTING <15 30-34 35+ TOTAL 
   per cent    
Yes 100.0 73.1 72.3 70.0 67.9 65.8 70.7
No – 26.9 27.7 30.0 32.1 34.2 29.3
Percent 100.0 100.0 100.0 100.0 100.0 100.0 100.0
N= 1 402 632 504 308 149 1996*
*Missing observations=54 
CURRENTLY SHARING BY SEX 
Within the group of those currently injecting was an even more at-risk group – those currently 
sharing equipment. We looked at this group in terms of their gender and age. It was to be 
expected from earlier information that, since proportionately more women than men were living 
with a drug-using partner, a higher proportion of females would be currently sharing injecting 
equipment and this indeed was the case -15 per cent of men and 25 per cent of women. 
Table 2.27 – Currently Sharing by Sex 
MALES FEMALES TOTAL CURRENTLY SHARING 
 per cent  
Yes 14.7 25.1 16.8
No 85.3 74.9 83.2
Per cent 100.0 100.0 100.0
N= 1398 366 1764*
*Missing observations=286 
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CURRENTLY SHARING BY AGE 
While a small minority of clients were currently sharing the proportion doing so was smallest in 
the 15-19 year old age group. This may probably be accounted for by the smaller proportion of 
those misusing opiates in that age group. 
Table 2.28 – Currently Sharing by Age 
<15 15-19 20-24 25-29 30-34 35+ TOTAL CURRENTLY SHARING 
   per cent    
Yes – 12.4 18.5 15.7 20.2 18.1 16.8
No 100.0 87.6 81.5 84.3 79.8 81.9 83.2
Percent – 100.0 100.0 100.0 100.0 100.0 100.0
N= 1 370 574 439 262 127 1773*
*Missing observations=277 
MAIN POINTS ARISING 
The proportion of males in this group of total treatment clients again constitutes the vast majority 
of the clients. The profile of the poorly educated, unemployed male as the commonest example of 
a client attending a drug treatment centre persists. Also the higher proportion of females than 
males living with a drug using partner also continues to be a feature in the data. 
On the Age variable we have seen confirmation of the slightly higher age mean for females, the 
increasing likelihood of early school leaving and lower level of achievement in the older age 
groups; the younger clients still living in their families of origin and the vast over-representation 
of the unemployed relative to their proportion in the general population. 
On the variable – primary drug of misuse – there was the dramatic change in the use of opiates 
from the younger teenagers to the older teenagers. In the use of hallucinogens, while the actual 
number and proportion of clients using these drugs is comparatively small -123 clients which 
constitutes 4.2 per cent of all clients – the drug most likely to be mentioned was exctasy. 
In looking at those clients who were currently injecting, it would appear that proportionately 
more females than males were currently injecting, but age did not appear to be important variable 
in whether a client was currently injecting or not. 
As we noted, proportionately more females were currently sharing than males but as far as age is 
concerned, after age 20 there did not appear to be any great difference in whether sharing or not. 
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CHAPTER 3 
Census of Clients in Treatment in December 
The data examined in this chapter refer to all clients receiving in-patient treatment on 31 
December 1993 or out-patient treatment during the month of December 1993. This is the Census 
date for the year 1994. As in the previous chapter we will deal separately with the data under the 
headings: 
(a) some socio-demographic characteristics; 
(b) aspects of the history of drug misuse; 
(c) facets of injecting and needle-sharing practices 
For comparison purposes we have retained the groupings in the tables in this chapter used in 
Chapter 2, although in some instances the numbers in the groups will be very small. 
The total number of clients in the Census was 728 persons. Of these, 75 per cent were males. 
Thirty-seven per cent were under 25 years old and 12 per cent were teenagers. Fifty-one per cent 
were still living with their family of origin, while 80 per cent were unemployed. Close on 9 out of 
10 came for treatment for an opiate problem. The mean age was 27.1 years – mean male age was 
26.9 years and the mean female age was 27.5. The Census clients are older than the clients in the 
other two groups. 
SECTION (a) – SOME SOCIO-DEMOGRAPHIC CHARACTERISTICS 
As in the previous chapter under (a) the socio-demographic characteristics to be examined will be 
sex of client; age of client; living status ; age client left school; level of education achieved and 
employment status. Tables 3.1 to 3.10 give the breakdown of these variables cross tabulated with 
sex and age. 
SEX 
The first variable we will look at is the sex of the clients crosstabulating this variable with age, 
education, living status and employment status. 
AGE 
Table 3.1 shows that the age structure for both males and females was fairly similar and no 
significant differences occurred. There was a slightly higher proportion of males in the under 15 
year age group. This was in contrast with the Prevalence group (Chapter 2) where the proportions 
were identical. This higher proportion of males followed through up to age 25 after which the 
female proportions were higher up to age 35 and similar for the 35+ category. In this 1994 
Census for both men and women the largest proportion was in the 25-29 year age group. 
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CHAPTER 3 
Census of Clients in Treatment in December 
The data examined in this chapter refer to all clients receiving in-patient treatment on 31 
December 1993 or out-patient treatment during the month of December 1993. This is the Census 
date for the year 1994. As in the previous chapter we will deal separately with the data under the 
headings: 
(a) some socio-demographic characteristics; 
(b) aspects of the history of drug misuse; 
(c) facets of injecting and needle-sharing practices 
For comparison purposes we have retained the groupings in the tables in this chapter used in 
Chapter 2, although in some instances the numbers in the groups will be very small. 
The total number of clients in the Census was 728 persons. Of these, 75 per cent were males. 
Thirty-seven per cent were under 25 years old and 12 per cent were teenagers. Fifty-one per cent 
were still living with their family of origin, while 80 per cent were unemployed. Close on 9 out of 
10 came for treatment for an opiate problem. The mean age was 27.1 years – mean male age was 
26.9 years and the mean female age was 27.5. The Census clients are older than the clients in the 
other two groups. 
SECTION (a) – SOME SOCIO-DEMOGRAPHIC CHARACTERISTICS 
As in the previous chapter under (a) the socio-demographic characteristics to be examined will be 
sex of client; age of client; living status ; age client left school; level of education achieved and 
employment status. Tables 3.1 to 3.10 give the breakdown of these variables cross tabulated with 
sex and age. 
SEX 
The first variable we will look at is the sex of the clients crosstabulating this variable with age, 
education, living status and employment status. 
AGE 
Table 3.1 shows that the age structure for both males and females was fairly similar and no 
significant differences occurred. There was a slightly higher proportion of males in the under 15 
year age group. This was in contrast with the Prevalence group (Chapter 2) where the proportions 
were identical. This higher proportion of males followed through up to age 25 after which the 
female proportions were higher up to age 35 and similar for the 35+ category. In this 1994 
Census for both men and women the largest proportion was in the 25-29 year age group. 
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Table 3.1 – Age by Sex 
MALES FEMALES TOTAL AGE 
 per cent  
<15 years 1.5 – 1.1
15-19 years 11.1 11.0 11.1
20-24 years 25.9 21.4 24.8
25-29 years 28.1 31.3 28.9
30-34 years 19.8 23.6 20.8
35 years+ 13.5 12.6 13.3
Per cent 100.0 100.0 100.0
N= 540 182 722*
*Missing observations=6 
Chi-sq=5.31271 with 5df. p<.378 
EDUCATION 
There were no significant differences between males and females in the age they left school or the 
education level they had reached before doing so. What is important to note, however, is that 41 
per cent of the clients had left school before the official school-leaving age of 15 years. 
Table 3.2 – Age Left School by Sex 
MALES FEMALES TOTAL AGE LEFT SCHOOL 
 per cent  
<15 years 42.2 38.9 41.4
15 years 27.7 26.8 27.5
16 years 15.9 18.1 16.4
17years+ 10.8 14.1 11.6
Still at school 3.5 2.0 3.1
Per cent 100.0 100.0 100.0
N= 491 149 640*
*Missing observations=88 
Chi-sq=2.51106 with 4df. p<642 
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Table 3.3 – Highest Level of Education Reached by Sex 
MALES FEMALES TOTAL LEVEL OF EDUCATION 
 per cent  
Primary 26.4 22.5 25.5
Secondary 69.5 71.1 69.8
Third Level 0.6 4.2 1.5
Still at school 3.6 2.1 3.2
Per cent 100.0 100.0 100.0
N= 478 142 620*
*Missing observations=108 
Chi-sq=l 1.14148 with 3df. p<.010 
LIVING STATUS 
The differences between males and females in their living status are significant. The proportion of 
males living with their family of origin is almost twice that of females whereas the proportion of 
females living with a drug using partner is four times that of males. Where men lived with a 
partner they were more likely to be living with a non-drug-user than with a drug user. On the 
other hand only six per cent of the female clients lived with a non-drug using partner and 45 per 
cent with a drug-using partner. 
Table 3.4 – Living Status by Sex 
MALES FEMALES TOTAL LIVING STATUS 
 per cent  
Alone 7.6 10.5 8.3
Family of origin 58.3 29.7 51.2
Partner drug user 11.6 45.3 20.1
Partner non-drug user 14.7 5.8 12.5
Institution/Homeless 1.6 0.6 1.3
Other 6.2 8.1 6.7
Per cent 100.0 100.0 100.0
N= 516 172 688*
*Missing observations=40 
Chi-sq=105.04076 with 5df. p<000 
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EMPLOYMENT STATUS 
Where a client was employed, this occurred for 15 per cent of the men but for an even lower 
proportion of women (4 per cent). Fifteen per cent of the women were classified as ‘housewife’. 
Overall there was, therefore, a slightly higher proportion of men in the category ‘unemployed’ 
than women. 
Table 3.5 – Employment Status by Sex 
MALES FEMALES TOTAL EMPLOYMENT STATUS 
 per cent  
Employed 14.7 4.4 12.1
Unemployed 81.0 78.6 80.4
Student 3.9 2.2 3.5
Housewife – 14.8 3.8
Others 0.4 – 0.3
Per cent 100.0 100.0 100.0
N= 537 182 719*
*Missing observations=9 
Chi-sq=93.54419 with 4df. p<000 
AGE 
We will now look at the selected socio-demographic variables by age. The numbers of clients in 
the Census group who were under 15 years old was very small (8 clients) all of them were male. 
The proportions of males to females in the other age groups were all around three to one in favour 
of males. 
Table 3.6 – Sex by Age 
<15 15-19 20-24 25-29 30-34 35+ Total Sex 
   per cent    
Males 100.0 75.0 78.2 72.7 71.3 76.0 74.8
Females – 25.0 21.8 27.3 28.7 24.0 25.2
Per cent 100.0 100.0 100.0 100.0 100.0 100.0 100.0
N= 8 80 179 209 150 96 722*
*Missing observations=6 
Chi-sq=5.31271 with 5df. p<.378 
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EDUCATION 
The older the client in treatment the more likely the client is to have left school before the age of 
15 years – 55 per cent of those in the 35 year old plus age group had done so, in comparison 
to/for instance 32 per cent in the 15-19 year age group. The number of missing observations for 
this variable is to be remarked on – 12 per cent on the age left school table and 15 per cent on the 
level of education table. 
Table 3.7 – Age Left School by Age 
<15 15.19 20-24 25-29 30-34 35+ TOTAL AGE LEFT SCHOOL 
   per cent    
<15 years – 31.6 34.9 44.2 47.0 54.7 41.5
15 years – 31.6 29.6 29.3 28.8 13.3 27.3
16 years – 14.5 18.9 16.0 17.4 14.7 16.5
17 years+ – 7.9 16.0 10.5 6.8 17.3 11.5
Still at school 100.0 14.5 0.6 – – – 3.1
Per cent 100.0 100.0 100.0 100.0 100.0 100.0 100.0
N= 8 76 169 181 132 75 641*
*Missing observations=87 
Chi-sq=319.58892 with 20df. P<.000 
 
Table 3.8 – Highest Level of Education Achieved by Age 
<15 15-19 20-24 25-29 30-34 35+ TOTAL LEVEL OF EDUCATION 
   per cent    
Primary – 15.5 17.4 30.3 32.6 32.4 25.6
Secondary – 67.6 82.0 68.5 64.3 64.9 69.7
Third Level – 1.4 – 1.1 3.1 2.7 1.4
Still at school 100.0 15.5 0.6 – – – 3.2
Per cent 100.0 100.0 100.0 100.0 100.0 100.0 100.0
N= 8 71 161 178 129 74 621*
*Missing observations = 107 
Chi-sq=311.70398 with 15df. P<.000 
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LIVING 
Up to 29 years old more than half of the clients in these age groups lived with their families of 
origin – in the case of the 15-19 year olds, 71 per cent did so. As might be expected, the older the 
client the more likely they were to be living with a partner and this was particularly noticeable 
where the client was living with a drug-using partner. 
Table 3.9 – Living Status by Age 
<15 15.19 20-24 25-29 30-34 35+ TOTAL LIVING STATUS 
   per cent    
Alone – 3.8 2.9 6.0 11.1 23.6 8.3 
Family 100.0 70.9 68.2 51.0 36.1 22.5 51.3 
Partner drug-user – 7.6 14.1 21.5 27.8 29.2 20.1 
Partner non-user – 3.8 7.6 16.0 16.0 15.7 12.3 
Institution/Homeless – – – 1.5 2.8 2.2 1.3 
Other – 13.9 7.1 4.0 6.3 6.7 6.7 
Percent 100.0 100.0 100.0 100.0 100.0 100.0 100.0 
N= 8 79 170 200 144 89 690* 
*Missing observations=38 
Chi-sq=123.87091 with 25df, p<.000 
EMPLOYMENT STATUS 
The employment status of the clients followed the same pattern as that of the total treatment 
clients where employment status was concerned. Even the 15-19 year old age group had an 
unemployment proportion of 75 per cent – the balance being students (15 per cent) and ten per 
cent of this group were in employment. 
Table 3.10 – Employment Status by Age 
<15 15-19 20-24 25-29 30-34 35+ TOTAL EMPLOYMENT STATUS 
   per cent    
Employed  – 10.0 10.6 16.3 12.1 8.3 12.1
Unemployed – 75.0 83.8 79.9 79.9 87.5 80.4
Student 100.0 15.0 1.7 0.5 1.0 3.5
Housewife – – 3.9 2.9 8.1 2.1 3.7
Other – – – 0.5 – 1.0 0.3
Per cent 100.0 100.0 100.0 100.0 100.0 100.0 100.0
N= 8 80 179 209 149 96 721*
*Missing observations=7 
Chi-sq=288.14651 with 20df. p<000 
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SECTION (b) – ASPECTS OF THE CLIENTS’ HISTORY OF DRUG MISUSE 
PRIMARY DRUG OF MISUSE 
Attention will now focus on the record of drug misuse by the clients in Census data 1994. 
In this section we will first correlate the variables sex and age with a number of other relevant 
variables which record the drug misuse of the clients. 
SEX 
With regard to sex and primary drug of misuse, as earlier noted 75 per cent of the clients in the 
1994 Census were males and 88 per cent of clients sought treatment for opiate abuse. In some 
instances the numbers in each category were too small to warrant comment. However where it 
was possible to comment in any meaningful way on the proportions of clients misusing a 
particular drug we noted that whereas females were misusing opiates at a level similar to their 
proportion in the population, this was not occurring where cannabis misuse was concerned. Also 
women were proportionately more likely to misuse hypnotics and sedatives and volatile inhalants 
than were men, but the numbers involved here were very small. We have retained some 
categories separately because this was important when the larger numbers in the Prevalence 
group (Chapter 2) were considered. Table 3.11 is a case in point. The differences here were 
significant at a p<.04 level. 
Table 3.11 – Primary Drug of Misuse by Sex 
MALES FEMALES TOTAL PRIMARY DRUG 
 per cent  
Opiates/Opioids 87.0 91.7 88.2
Hypnotics/Sedatives 1.9 2.8 2.1
Hallucinogens 2.6 3.9 2.9
Volatile Inhalants 0.7 – 0.6
Cannabis 7.1 1.7 5.7
Other 0.7 – 0.6
Per cent 100.0 100.0 100.0
N= 539 180 719*
*Missing observations=9 
Chi-sq=11.18199 with 5df. p<.047 
AGE 
As in the previous chapter the mean age of the clients was calculated by primary drug. The details 
are as follows: 
Opiates/Opioids 27.9 N=612 
Stimulants 21.3 N=3 
Hypnotics/Sedatives 28.3 N=15 
Hallucinogens 20.2 N=20 
Volatile Inhalants 14.3 N=4 
Cannabis 19.7 N=40 
Other drugs 15.0 N=1 
All Drugs 27.1 N=728 
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As may be seen from the above the vast majority of the clients were in treatment for misusing an 
opiate/opioid as their primary drug and the mean age of the clients was a little older than that for 
all drugs. Clients whose primary drug was an hypnotic or sedative did have a slightly older mean 
age but there were only 15 clients in that category. 
When correlating primary drug of misuse by age Table 3.12 shows that in the under 15 age group 
(a very small group anyway) there were no opiate/opioid misusers but in the group 15-19 the 
proportion is 49 per cent with 27 per cent being cannabis users. In all the other age categories the 
primary drug was an opiate or opioid in over 88 per cent of the cases. 
Table 3.12 – Primary Drug of Misuse by Age 
<15 15-19 20-24 25-29 30-34 35+ TOTAL PRIMARY DRUG 
   per cent    
Opiates/Opioids – 48.7 87.8 98.1 95.3 93.8  88.1
Hypnotics/Sedatives – 3.8 1.1 0.5 4.0 3.1 2.1
Hallucinogens – 16.7 4.4 – – 1.0 3.1
Volatile Inhalants 42.9 1.3 – – – – 0.6
Cannabis 57.1 26.9 6.1 0.9 0.7 2.1 5.7
Others – 2.6 0.6 0.5 – – 0.6
Per cent 100.0 100.0 100.0 100.0 100.0 100.0 100.0
N= 7 78 180 211 149 96 721*
*Missing observations=7 
Chi-sq=441.27891 with 25df. p<.000 
AGE PRIMARY DRUG FIRST USED BY PRIMARY DRUG 
In this section we first look at the primary drug by the age at which it was first used. Given that 
Table 3.12 showed there were no opiate users in the under 15 year old group, it is interesting to 
see from Table 3.13 that 65 per cent of the clients said that they were under 15 years old when 
they first used a drug and that that drug was an opiate/opioid. These are obviously the older 
clients now. The proportions who said they had first used when they were between 15 and 19 
years old and whose first drug was an opiate/opioid was 87 per cent. 
Table 3.13 – Primary Drug by Age Primary Drug First Used 
<15 15-19 20-24 25+ TOTAL PRIMARY DRUG 
  per cent   
Opiates/Opioids 64.6 87.1 96.3 97.0 88.1
Hypnotics/Sedatives 6.3 1.7 1.2 2.0 2.2
Hallucinogens 2.5 4.2 1.9 - 2.9
Volatile Inhalants 5.1 - - - 0.6
Cannabis 20.3 6.5 - 1.0 5.8
Others 1.3 0.6 0.6 - 0.6
Per cent 100.0 100.0 100.0 100.0 100.0
N= 79 356 161 99 695*
*Missing observations=33 Chi-sq=94.87483 with 15df. p<000 
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Table 3.13A – Age Primary Drug First Used by Primary Drug 
 AGE FIRST 
USED OP/OPIOID HYP/SED HALLUC VOLIN CANNAB OTHERS TOTAL 
    per cent    
<15 years 8.3 33.3 10.0 100.0 40.0 25.0 11.4
15-19 years 50.7 40.0 75.0 – 57.5 50.0 51.2
20-24 years 25.3 13.3 15.0 – – 25.0 23.3
25 years+ 15.7 13.3 – – 2.5 – 14.2
Per cent 100.0 100.0 100.0 100.0 100.0 100.0 100.0
N= 612 15 20 4 40 4 695*
*Missing observation=33 
Chi-sq=94.87483 with 15df. p<.000 
AGE PRIMARY DRUG FIRST USED BY SEX AND AGE 
In the crosstabulation of the variable sex by age their stated primary drug first used, the question 
here was were males more likely to misuse at a younger age than females? In this census group 
the data showed that the differences in the ages at which males and females first used their 
primary drug were not significant, although it seemed that proportionately more females were in 
the under 15 year old group when they first used their primary drug. We have not included a table 
here. 
DURATION OF USE OF PRIMARY DRUG BY PRIMARY DRUG 
Under this heading we will first look at the actual duration of use by the primary drug and then 
look at duration of use by sex and age. Again where numbers justify comment, it seems that 
where opiates and opioids are concerned the misuse is of longer duration than for other drugs 
apart from hypnotics and sedatives. 
Table 3.14 – Duration of Use of Primary Drug by Primary Drug 
OP/OPIOID HYP/SED HALLUC VOLIN CANNAB OTHERS TOTAL USED DURATION 
OF USE    per cent    
<1 year 0.5 – 10.0 25.0 13.2 – 1.6
1-2 years 21.0 20.0 65.0 75.0 31.6 25.0 23.2
3-4 years 18.9 – 10.0 – 18.4 50.0 18.2
5-9 years 24.9 46.7 10.0 – 23.7 25.0 24.7
10 years+ 34.7 33.3 5.0 – 13.2 – 32.2
Per cent 100.0 100.0 100.0 100.0 100.0 100.0 100.0
N= 599 15 20 4 38 4 680*
*Missing observations=48 
Chi-sq=105.38598 with 20df. p<000 
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DURATION AND FREQUENCY OF USE BY SEX AND AGE 
SEX 
In Table 3.15 no significant differences between males and females were observed in the duration 
of use of their primary drug – although females did appear to have been misusing just slightly 
longer than males before entering treatment. 
Table 3.15 – Duration of Use of Primary Drug by Sex 
MALES FEMALES TOTAL DURATION OF USE 
 per cent  
<1 year 1.6 1.7 1.6
1-2 years 23.9 22.4 23.5
3-4 years 20.2 12.6 18.2
5-9 years 23.7 26.4 24.4
10 years+ 30.6 36.8 32.2
Per cent 100.0 100.0 100.0
N= 506 174 680*
*Missing observations=48 
Chi-sq=6.06236 with 4df. p<194 
Where frequency of use, that is frequency during the past month, was concerned, differences 
between the sexes in their frequency of use did appear to be significant – females being in the 
lower frequency use groups. 
Table 3.16 – Frequency of Use of Primary Drug by Sex 
MALES FEMALES TOTAL FREQUENCY OF USE 
IN PAST MONTH  per cent  
Drug free 13.1 15.7 13.7
Less than once weekly 3.4 11.2 5.3
Once weekly 2.4 1.1 2.1
Twice weekly 8.8 7.3 8.4
Daily 33.1 25.3 31.1
Twice or more daily 39.3 39.3 39.3
Per cent 100.0 100.0 100.0
N= 535 178 713*
*Missing observations=15 
Chi-sq=20.25193 with 5df. p<001 
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AGE 
Turning to age now as is to be expected the younger the client the shorter the duration of use and 
this is evident from Tables 3.17 and 3.17A. 
Table 3.17 – Duration of Use of Primary Drug by Age 
<15 15-19 20-24 25-29 30-34 35+ TOTAL DURATION 
   per cent    
<1 year 50.0 5.3 0.6 0.5 0.7 – 1.6
1-2 years 50.0 72.0 32.6 16.0 7.8 5.4 23.6
3-4 years – 18.7 34.3 17.5 9.9 4.3 18.3
5-9 years – 4.0 29.7 32.0 27.7 13.0 24.5
10 years+ – – 2.9 34.0 53.9 77.2 32.0
Per cent 100.0 100.0 100.0 100.0 100.0 100.0 100.0
N= 8 75 172 194 141 92 682*
*Missing observations =46 
Chi-sq=462.12465 with 20df. p<-000 
 
Table 3.17A – Age by Duration of Use of Primary Drug 
AGE <1 year 1-2 yrs 3-4 yrs 5-9 yrs 10yrs+ TOTAL 
per cent 
<1 years 36.4 2.5 – – – 1.2
15-19 years 36.4 33.5 11.2 1.8 - 11.0
20-24 years 9.1 34.8 47.2 30.5 2.3 25.2
25-29 years 9.1 19.3 27.2 37.1 30.3 28.4
30-34 years 9.1 6.8 11.2 23.4 34.9 20.7
35 years + – 3.1 3.2 7.2 32.6 13.5
Per cent 100.0 100.0 100.0 100.0 100.0 100.0
N= 11 161 125 167 218 682*
*Missing observations=46 
Although, as with duration of use of primary drug, the frequency of use increased by age there 
was not quite the dramatic difference between the age groups once the under 15s were excluded. 
In fact the proportions in the groups of those aged 15 and over who use daily or more often were 
all more than 53 per cent whereas this did not occur until the 25-29 year age group for duration of 
use of primary drug. 
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Table 3.18 – Frequency of Use of Primary Drug by Age 
<15 15-19 20-24 25-29 30-34 35+ TOTALFREQUENCY OF USE 
IN PAST MONTH    per cent    
Drug free 75.0 16.5 13.4 10.0 14.2 14.1 13.7
Less than once weekly 25.0 7.6 7.3 2.9 5.4 3.3 5.3
Once weekly – 7.6 1.7 1.0 1.4 2.2 2.1
Twice weekly – 15.2 11.2 4.8 5.4 10.9 8.4
Daily – 38.0 32.4 33.5 25.7 28.3 31.0
Twice or more daily – 15.2 34.1 47.8 48.0 41.3 39.4
Per cent 100.0 100.0 100.0 100.0 100.0 100.0 100.0
N= 8 79 179 209 148 92 715*
*Missing observations=13 
Chi-sq=89.58463 with 25df. p<000 
FREQUENCY OF USE OF PRIMARY DRUG BY ROUTE OF ADMINISTRATION 
The final cross-tabulation here is that of frequency of use by route of administration of primary 
drug. Injecting was the most frequently used method with eating or drinking being the next most 
frequently used. 
Table 3.19 – Frequency of Use by Route of Administration of Primary Drug 
INJECT SMOKE EAT/DRINK SNIFF TOTAL FREQUENCY OF USE 
IN PAST MONTH   per cent   
Drug free 9.6 12.2 10.4 60.0 10.3
Less than once weekly 4.2 13.5 6.5 20.0 5.5
Once weekly 1.3 6.8 3.9 – 2.2
Twice weekly 7.0 16.2 14.3 – 8.7
Daily 30.8 32.4 40.3 20.0 31.9
Twice or more daily 47.2 18.9 24.7 – 41.3
Per cent 100.0 100.0 100.0 100.0 100.0
N= 530 74 77 5 686*
*Missing observations=42 
Chi-sq=67.30873 with 15df. p<.000 
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ROUTE OF ADMINISTRATION OF PRIMARY DRUG BY PRIMARY DRUG 
For this Census group, as might be expected/the vast majority (88 per cent) of those citing an 
opiate or opioid as their primary drug injected and those citing cannabis smoked their primary 
drug. Although the numbers in the other categories are very small, the proportions in the routes of 
administration follow expected lines. 
Table 3.20 – Route of Administration of Primary Drug by Primary Drug 
OP/OPIOID HYP/SED HALLUC VOLIN CANNAB OTHERS TOTAL ROUTE OF 
ADMIN.    per cent    
Inject 87.7 6.7 – – – – 77.7
Smoke 5.6 – 4.5 – 97.5 33.3 10.8
Eat/Drink 6.7 93.3 90.9 – 2.5 66.7 11.3
Sniff – – 4.5 100.0 – – 0.7
Percent 100.0 100.0 100.0 100.0 100.0 100.0 100.0
N= 608 15 22 4 40 3 692*
*Missing observations=36 
ROUTE OF ADMINISTRATION BY SEX AND AGE 
Females were slightly more likely to inject than were males. Whether this was caused by the 
higher proportion of females living with a drug-using partner or not is impossible to tell without 
some investigation into that possibility. 
Table 3.21 – Route of Administration of Primary Drug by Sex 
 ROUTE OF 
ADMINISTRATION MALES FEMALES TOTAL 
  per cent  
Inject 76.1 80.6 77.2
Smoke 12.4 6.5 10.9
Eat/Drink 10.8 12.4 11.2
Sniff 0.8 0.6 0.7
Per cent 100.0 100.0 100.0
N= 518 170 688*
*Missing observations=40 
Chi-sq=4.73725 with 3df. p<192 
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The dramatic differences in the behaviour between the youngest age groups and the older ones is 
demonstrated again in the following tables. In each of the age groups over 20 the proportions of 
injectors is well over three-quarters. If we add the numbers in the two youngest groups (under 15 
and 15-19) the proportion injecting becomes 34.9 per cent; smoking 38.6; eating/drinking 20.5 
and sniffing 6 per cent. The largest proportion for the younger age groups is therefore smoking 
and not injecting. 
Table 3.22 – Route of Administration by Primary Drug by Age 
<15 15-19 20-24 25-29 30-34 35+ Total ROUTE OF 
ADMINISTRATION    per cent    
Inject – 38.2 77.4 86.6 87.9 77.0 77.1
Smoke 57.1 36.8 12.4 3.0 3.5 11.5 10.9
Eat/Drink – 22.4 10.2 10.4 8.5 11.5 11.3
Sniff 42.9 2.6 – – – – 0.7
Per cent 100.0 100.0 100.0 100.0 100.0 100.0 100.0
N= 7 76 177 202 141 87 690*
*Missing observations=38 
Chi-sq==294.85352 with 15df. p<.000 
 
Table 3.22A – Age by Route of Administration of Primary Drug 
INJECT SMOKE EAT/DRINK SNIFF TOTAL AGE 
  per cent   
<15 years – 5.3 – 60.0 1.0
15-19 years 5.5 37.3 21.8 40.0 11.0
20-24 years 25.8 29.3 23.1 – 25.7
25-29 years 32.9 8.0 26.9 – 29.3
30-34 years 23.3 6.7 15.4 – 20.4
35 years+ 12.6 13.5 12.8 – 12.6
Per cent 100.0 100.0 100.0 100.0 100.0
N= 532 75 78 5 690*
*Missing observations=38 
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SECTION (c) FACETS OF INJECTING AND NEEDLE-SHARING PRACTICES. 
CLIENTS WHO HAD EVER INJECTED. 
SEX 
Of the group of clients who had ever injected in the 1994 Census 69 per cent of males were 
currently injecting and 67 per cent of females, indicating that females were only slightly less 
likely to be currently injecting than males. (Table 3.23). 
Table 3.23 – Currently Injecting by Sex 
MALES FEMALES TOTAL CURRENTLY INJECTING 
 per cent  
Yes 68.7 66.5 68.1
No 31.3 33.5 31.9
Per cent 100.0 100.0 100.0
N= 435 161 596*
*Missing observations=19 
AGE 
The age group is excluded here as there were no clients in that group. One notable figure was the 
proportionate rise in the group 15-19 who were injecting from no clients in the under 15 group to 
74 per cent of the 15-19 year age group. This was the highest proportion in any of the age groups. 
However, the relatively small number involved must be taken into account. 
Table 3.24 – Currently Injecting by Age 
15-19 20-24 25-29 30-34 35+ Total CURRENTLY INJECTING 
  per cent    
Yes 74.3 70.9 67.0 64.3 69.5 68.1
No 25.7 29.1 33.0 35.7 30.5 31.9
Percent 100.0 100.0 100.0 100.0 100.0 100.0
N= 35 141 200 140 82 598*
*Missing observations = 17 
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CURRENTLY SHARING BY SEX 
Of these clients who had ever injected – were they currently sharing injecting equipment? Tables 
3.25 and 3.26 show whether or not by sex and age. With regard to sex the higher proportion of 
females currently sharing would again appear to reflect the higher proportion of females who 
were living with a drug-using partner. This may or may not be the explanation. Without further 
investigation it is impossible to say. 
Table 3.25 – Currently Sharing by Sex 
MALES FEMALES TOTAL CURRENTLY SHARING 
 per cent  
Yes 18.6 25.4 20.4
No 81.4 74.6 79.6
Per cent 100.0 100.0 100.0
N= 381 138 519*
*Missing Observations= 96 
CURRENTLY SHARING BY AGE 
Where age was concerned while no under 15s were currently injecting and therefore would not be 
currently sharing injecting equipment – one-third of those in the 15-19 year age group were 
currently sharing. The proportion in this age group only amounts to 6 per cent of the total of 
clients currently injecting, but 9 per cent of those who are currently sharing. 
Table 3.26 – Currently Sharing by Age 
15-19 20-24 25-29 30-34 35+ Total CURRENTLY INJECTED 
  per cent    
Yes 33.3 22.9 16.9 18.3 23.6 20.6
No 66.7 77.1 83.1 81.7 76.4 79.4
Percent 100.0 100.0 100.0 100.0 100.0 100.0
N= 30 131 172 115 72 520*
*Missing observations = 95 
MAIN POINTS ARISING 
The Census clients, the concern of this chapter, had similar characteristics to those of the total 
treatment group except in some areas. For instance, their mean age was older than that of either of 
the other two groups and there was proportionately more women in the Census group. These in 
turn may have led to the other differences. A higher proportion had left school before the school-
leaving age of 15 – 41 per cent in contrast with 33 per cent of total treatment clients and 25 per 
cent of first treatment clients; obviously a smaller proportion lived with their family of origin; a 
longer duration of use of their primary drug; a higher proportion of clients injecting in the group, 
and although slightly smaller proportion currently injecting, of those there was a higher 
proportion sharing. Otherwise, in terms of the other variables, similar proportions were found. 
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CHAPTER 4 
First Treatment Contacts 
The data to be examined in this chapter refer to clients who entered treatment for the first time 
ever during 1994, as defined in Chapter 1. The tables are based on valid percentages but give the 
number of missing observations. As in the previous chapters the data will be dealt with under the 
following headings: 
(a) some socio-demographic characteristics; 
(b) aspects of the clients’ history of drug misuse; 
(c) facets of the clients’ injecting and needle-sharing practices. 
During 1994 the total number of clients who received treatment for the first time was 1150. 
Eighty-four per cent were under 25 and in fact 51 per cent were teenagers. The vast majority were 
males – 84 per cent; over three-quarters were living with their family of origin (77 per cent) and 
more than 80 per cent were unemployed. 
As with the other groups (Chapters 2 and 3), opiates and opioids were the drugs which were 
mentioned by the clients as their primary drug of misuse. This was the case in 1994 for almost 
three-quarters of the first treatment clients. As in other years these proportions were not as high as 
for the total treatment or census groups, but were certainly approaching the proportions in those 
groups. The mean age of the clients in this first treatment group was 20.6 years – for males it was 
20.5 and for females 21.3 years. 
SECTION (a) – SOME SOCIO-DEMOGRAPHIC CHARACTERISTICS 
As in the earlier chapters in this section we will concentrate on cross-tabulation of the available 
socio-demographic variables with sex and age. Tables 4.1 to 4.10 will give the breakdowns. 
SEX 
AGE 
The overall picture of sex by age is that during 1994 while just over half (51 per cent) of the 
clients were teenagers, proportionately more males were teenagers than females (52 per cent of 
males and 45 per cent of females). A further one-third of the clients were in the 20-24 year age 
group and here the proportions of males and females were much closer in size. 
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Table 4.1 – Age by Sex 
MALES FEMALES TOTAL AGE 
 per cent  
<15 years 3.2 5.4 3.5
15-19 years 48.9 39.5 47.4
20-24 years 33.0 34.1 33.2
25-29 years 8.7 11.9 9.2
30-34 years 4.3 8.6 5.0
35 years+ 1.9 0.5 1.7
Per cent 100.0 100.0 100.0
N= 952 185 1137*
*Missing observations = 13 
Chi-sq=14.32405 with 5df. p<013 
EDUCATION 
The two variables used here are the age the client left school and the level of education he or she 
reached while attending school. Taking first the age at which clients left school by sex, Table 4.2 
shows that there were no significant sex differences here – the only noticeable difference is where 
clients are still at school. It appears that slightly more females than males are still at school. The 
vast majority (three-quarters) of both males and females had some secondary education. 
 
 
 
Table 4.2 – Age left School by Sex 
MALES FEMALES TOTAL AGE LEFT SCHOOL 
 per cent  
<15 years 26.8 24.9 26.5
15 years 24.1 23.8 24.1
16 years 25.2 23.2 24.9
17 years+ 15.8 16.0 15.8
Still in Education 7.7 12.2 8.5
Never in Education 0.3 – 0.3
Per cent 100.0 100.0 100.0
N= 907 181 1088*
*Missing observations=62 
Chi-sq=4.59257 with 5df. p<.467 
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Table 4.3 – Highest Level of Education Reached by Sex 
LEVEL OF EDUCATION MALES FEMALES TOTAL 
  per cent  
Primary 12.7 10.2 12.3
Secondary 78.0 74.4 77.4
Third Level 1.2 2.8 1.5
Still in Education 7.8 12.5 8.5
Never in Education 0.3 – 0.3
Per cent 100.0 100.0 100.0
N= 903 176 1079*
*Missing observations=71 
Chi-sq=8.08373 with 4df. p<.088 
LIVING STATUS BY SEX 
While around 80 per cent of the male clients were living with their families of origin, the 
proportion of females was a great deal smaller (61 per cent). As in other years, of particular note 
here was the higher proportion of females living with a drug-using partner (2 per cent of males, 
13 per cent of females). 
Table 4.4 – Living Status by Sex 
MALES FEMALES TOTAL LIVING STATUS 
 per cent  
Alone 2.8 9.9 4.0
Family of origin 80.2 61.2 77.1
Partner drug user 2.1 13.3 3.9
Partner non-drug user 6.2 4.4 5.9
Institution/Homeless 2.8 5.0 3.2
Other 6.0
Per cent 100.0 100.0 100.0
925 181 1106*
*Missing observations=44 
Chi-sq=78.28108 with 5df. p<.000 
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EMPLOYMENT STATUS 
Where employment status is concerned, given the data in our previous reports, it was not 
surprising to find that over four-fifths of the male clients were unemployed and three-quarters of 
the female clients. 
Table 4.5 – Employment Status by Sex 
EMPLOYMENT STATUS MALES FEMALES TOTAL 
  per cent  
Unemployed 82.9 75.5 81.7
Employed 9.3 11.7 9.7
Student 7.4 11.7 8.1
Housewife – 1.1 0.2
Per cent 100.0 100.0 100.0
N= 944 188 1132*
*Missing Observations= 18 
Chi-sq=16.15335 with 4df. p<.002 
AGE 
When looking at sex by age, the evidence of the overwhelming proportion of males who are in 
treatment for the first time in 1994 is obvious. In all the age groups the proportions of males 
outweigh females and in only one age group – 30-34 years is it any less than three to one. 
Table 4.6 – Sex by Age 
<15 15-19 20-24 25-29 30-34 35+ TOTAL SEX 
   per cent    
Males 75.0 86.5 83.2 79.2 71.9 94.7 83.7
Females 25.0 13.5 16.8 20.8 28.1 5.3 16.3
Per cent 100.0 100.0 100.0 100.0 100.0 100.0 100.0
N= 40 539 376 106 57 19 1137*
*Missing observations=13 
Chi-sq=14.32405 with 5df. p<.013 
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EDUCATION 
As the age of the clients increases the proportion who have left school before the official school 
leaving age of 15 increases. While overall 8 per cent of clients were still in education, as was to 
be expected the vast majority of those in the under 15 year age group were still in education. 
These results are borne out by information in Table 4.8 which gives the level of education 
achieved by the clients. Less than 2 per cent had reached Third Level status. 
Table 4.7 – Age Left School by Age 
AGE LEFT SCHOOL <15 15-19 20-24 25-29 30-34 35+ TOTAL 
    per cent    
<15 years 17.9 30.4 18.9 26.5 35.8 44.4 26.3
15 years – 25.3 26.7 23.5 17.0 5.6 24.0
16 years – 22.6 33.4 22.4 22.6 11.1 25.2
17years + – 11.2 20.3 26.5 22.6 27.8 16.0
Still in Education 82.1 10.5 0.6 1.0 – – 8.2
Never in Education – – – – 1.9 11.1 0.3
Per cent 100.0 100.0 100.0 100.0 100.0 100.0 100.0
N= 39 526 359 98 53 18 1093*
*Missing observations=57 
Chi-sq=464.48042 with 25df. p<.000 
 
Table 4.8 – Highest Level of Education Reached by Age 
LEVEL OF EDUCATION <15 15-19 20-24 25-29 30-34 35+ TOTAL 
    per cent    
Primary 5.3 11.8 11.2 13.4 20.0 31.6 12.3
Secondary 10.5 76.8 86.3 84.5 72.7 52.6 77.7
Third Level – 0.8 2.0 1.0 5.5 5.3 1.5
Still in Education 84.2 10.6 0.6 1.0 – – 8.3
Never in Education – – – – 1.8 10.5 0.3
Per cent 100.0 100.0 100.0 100.0 100.0 100.0 100.0
N= 38 518 357 97 55 19 1084*
*Missing observations=66 
Chi-sq=433.82102 with 20df. p<-000 
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LIVING STATUS 
The living status by age of the first treatment clients shows, as might be expected, a decreasing 
proportion of clients in the older age groups still living with their family of origin and a 
consequent increase in the proportions living with a partner, either a drug user or non-drug user. 
Table 4.9 – Living Status by Age 
LIVING STATUS <15 15-19 20-24 25-29 30-34 35+ TOTAL 
 per cent 
Alone – 0.6 6.6 8.1 11.3 15.8 4.0
Family of origin 85.0 88.8 75.0 52.5 35.8 26.3 77.2
Partner drug user – 0.9 6.6 7.1 11.3 5.3 3.9
Part. non-drug user – – 5.5 22.2 26.4 47.4 5.9
Institution/Homeless 10.0 3.9 0.5 4.0 5.7 – 3.1
Other 5.0 5.8 5.8 6.1 9.4 5.3 6.0
Per cent 100.0 100.0 100.0 100.0 100.0 100.0 100.0
N= 40 534 364 99 53 19 1109*
*Missing observations=41 
Chi-sq=299.34066 with 25df. p<000 
EMPLOYMENT STATUS 
Turning to age by employment status, at all age groups except the under 15s, well over three-
quarters of the clients were unemployed. This compares very unfavourably with the proportion of 
unemployed in the general population which is one of the highest in the EU. This finding 
highlights once again one of the main characteristics of clients attending treatment centres, either 
for the first time or at any time as noted in Chapter 2. 
Table 4.10 – Employment Status by Age 
EMPLOYMENT STATUS <15 15-19 20-24 25-29 30-34 35+ TOTAL 
    per cent    
Unemployed  17.5 82.4 88.4 83.0 77.2 88.9 81.9
Employed 2.5 7.2 10.5 15.1 22.8 11.1 9.7
Student 80.0 10.1 0.5 0.9 – – 7.9
Housewife – – 0.3 0.9 – – 0.2
Other – 0.4 0.3 – – – 0.3
Per cent 100.0 100.0 100.0 100.0 100.0 100.0 100.0
N= 40 544 370 106 57 18 1135*
*Missing observations = 15 
Chi-sq=350.67832 with 20df. p<.000 
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SECTION (b) – ASPECTS OF THE CLIENTS’ HISTORY OF DRUG MISUSE 
PRIMARY DRUG OF MISUSE 
In the tables following we examine the socio-demographic variables cross-tabulated by the 
history of the clients’ drug misuse. Primary drug of misuse refers to the drug which caused the 
greatest problem for the client and which precipitated the client’s into seeking treatment. As 
previously noted almost three-quarters of the clients treated for drug misuse in 1994 mentioned an 
opiate or opioid drug as their primary drug of misuse. 
SEX 
Where primary drug by sex is concerned, there was a slightly higher proportion of males than 
females citing an opiate/opioid as their primary drug of misuse (75 per cent of males; 72 percent 
of females). This was also the case for cannabis. Females were more likely to misuse 
hallucinogens and hypnotics and sedatives than were males. The difference between the sexes on 
primary drug is significant at p<.06 level. 
Table 4.11 – Primary Drug of Misuse by Sex 
PRIMARY DRUG  MALES FEMALES TOTAL 
 per cent  
Opiates/opioids  75.0 71.8 74.5
Hypnotics/Sedatives  0.8 1.6 1.0
Hallucinogens  5.5 8.5 6.0
Volatile Inhalants  1.1 1.6 1.1
Cannabis  16.9 13.8 16.4
Other  0.7 2.7 1.1
Per cent  100.0 100.0 100.0
N=  952 188 1140*
*Missing observations=10 
Chi-sq=10.43032 with 5df. p<.06  
AGE 
If we inspect the mean ages of first treatment clients by primary drug the details are as follows: 
Opiates/Opioids: 21.1 years N=852 
Stimulants 21.9 years N=7 
Hypnotics/Sedatives. 28.2 years N=11 
Hallucinogens 18.9 years N=68 
Volatile Inhalants 13.9 years N=12 
Cannabis 19.4 years N=188 
Other drugs 15.7 years N=5 
All drugs 20.6 years N=1150 
The numbers in some of the categories are extremely small, so taking that into account, the oldest 
group, with only eleven members, is the group of clients whose primary drug is an 
hypnotic/sedative. The mean age of the opiate/opioid users is the oldest of the groups that could 
be seriously considered because of their size. Both cannabis users and users of hallucinogens 
have a mean age of under 20 years old. 
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Considering the misuse of primary drug in the more detailed age groups, as might be expected 
there were significant differences between the age groups (p<.000). Table 4.12 shows the 
dramatic rise in the proportion of clients whose primary drug of misuse was an opiate from ten 
per cent in the under 15 year old age group to 72 per cent in the 15-19 year olds. In all the older 
age groups, with the exception of the 35+ year olds, which is a very small group anyway, 
proportions are in excess of 75 per cent. 
Table 4.12 – Primary Drug of Misuse by Age 
PRIMARY DRUG <15 15-19 20-24 25-29 30-34 35+ TOTAL 
    per cent    
Opiate/Opioid 10.0 72.3 83.5 76.4 82.5 63.2 74.5
Hypnotics/Sedatives 2.5 0.6 0.3 0.9 1.8 21.1 1.0
Hallucinogens 17.5 6.8 5.3 3.8 – – 5.9
Volatile Inhalants 25.0 0.4 – – – – 1.0
Cannabis 42.5 19.3 9.8 17.0 14.0 15.8 16.4
Other 2.5 0.7 1.1 1.9 1.8 – 1.0
Percent 100.0 100.0 100.0 100.0 100.0 100.0 100.0
N= 40 545 376 106 57 19 1143*
*Missing observations=7 
Chi-sq=385.43085 with 25df. p<.000 
PRIMARY DRUG BY AGE PRIMARY DRUG FIRST USED 
When we looked at the primary drug of misuse by the age at which that drug was first used, 
almost half (47 per cent) of those who were under 15 when they first used their primary drug had 
used cannabis and just over a quarter had used an opiate or opioid. This is in contrast to the 
proportions of the clients who had first used their primary drug at aged 15 or over. Table 4.13 
shows that the proportion in the 15-19 year old age group was 81 per cent using an opiate/opioid 
when they first used their primary drug. 
Table 4.13 – Primary Drug by Age Primary Drug First Used 
<15 15-19 20-24 25+ TOTAL PRIMARY DRUG 
 per cent    
Opiates/Opioids 26.3 81.3 81.0 86.4 75.0
Hypnotics/Sedatives 1.5 0.4 1.2 3.0 0.8
Hallucinogens 15.0 4.5 6.1 1.5 5.8
Volatile Inhalants 9.0 – – – 1.1
Cannabis 47.4 13.0 9.2 7.6 16.2
Other 0.8 0.8 2.5 1.5 1.1
Percent 100.0 100.0 100.0 100.0 100.0
N= 133 756 163 66 1118*
*Missing observations=32 
Chi-sq=263.84244 with 15df. p<000 
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Table 4.13A – Age Primary Drug First Used by Primary Drug 
OP/OPIOID HYP/SED HALLUC VOLIN CANNAB OTHER TOTAL AGE FIRST 
USED    per cent    
<15 years 4.2 22.2 30.8 100.0 34.8 8.3 11.9
15-19 years 73.3 33.3 52.3 - 54.1 50.0 67.6
20-24 years 15.7 22.2 15.4 - 8.3 33.3 14.6
25 years + 6.8 22.2 1.5 - 2.8 8.3 5.9
Per cent 100.0 100.0 100.0 100.0 100.0 100.0 100.0
N= 839 9 65 12 181 12 1118*
*Missing observations=32 
AGE PRIMARY DRUG FIRST USED BY SEX 
The age groups at which the primary drug was first used by the client differed significantly by sex 
(p<.000). Males were proportionately more evident in the 15-19 year age group – only half of the 
females in contrast to seven out of ten males were in that age group 
Table 4.14 – Age Primary Drug First Used by Sex 
AGE FIRST USED MALES FEMALES TOTAL 
  per cent  
<15 years 10.7 18.1 11.9
15-19 years 70.6 50.8 67.5
20-24 years 13.3 22.0 14.7
25 years + 5.4 9.0 5.9
Per cent 100.0 100.0 100.0
N= 933 177 1110*
*Missing observations=40 
Chi-sq=26.54398 with 3df. p<.000 
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DURATION OF USE OF PRIMARY DRUG BY PRIMARY DRUG 
The duration of the use of each of the primary drugs for this group of first treatment clients shows 
that except for hypnotics and sedatives, around or over 50 per cent of the clients had been using 
between one and two years before coming for treatment. Clients misusing hypnotics and sedatives 
were more likely to be misusing for a longer period before entering treatment. The number here is 
extremely small, so no great cognizance may be given to that result. 
Table 4.15 – Duration of Use of Primary Drug by Primary Drug 
DURATION OF USE OP/OP. HYP/SED HALLUC VOLIN CANNAB OTHER 
<1 year 4.1 12.5 18.5 33.3 7.5 41.7 6.2
1-2 years 63.5 25.0 58.3 46.6 50.0 59.8
3-4 years 21.4 – 20.0 8.3 21.8 8.3 20.9
5-9 years 6.0 25.0 7.7 – 18.4 – 8.0
10 years + 5.1 37.5 – – 5.7 – 5.0
Per cent 100.0 100.0 100.0 100.0 100.0 100.0 100.0
N= 838 8 12 174 12 1109*
*Missing observations=41 
Chi-sq=128.07626 with 20df. p<.000 
TOTAL 
 per cent 
53.8
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DURATION AND FREQUENCY OF USE OF PRIMARY DRUG BY SEX AND AGE 
SEX 
Looking first at sex by duration and frequency of use, the length of time during which a client 
would have used their primary drug before coming for treatment does vary significantly with the 
sex of the client (see Table 4.16). Females appear to have been misusing their primary drug for a 
shorter period before presenting for treatment. 
Table 4.16 – Duration of Use of Primary Drug by Sex 
DURATION OF USE MALES FEMALES TOTAL 
 per cent 
<1 year 4.9 13.4 6.3
1-2 years 
21.9 16.2 21.0
8.2 7.3 8.1
10 years + 4.8 6.7 5.1
Per cent 100.0 100.0 100.0
N= 923 179 1102*
*Missing observations=48 
Chi-Sq=21.39059 with 4 df. p<.000 
60.2 56.4 59.6
3-4 years 
5-9 years 
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Table 4.16A – Sex by Duration of Use of Primary Drug 
SEX <1yr l-2yrs 3-4yrs 5-9yrs 10yrs+ TOTAL
 per cent 
Males 65.2 84.6 87.4 85.4 78.6 83.8
Females 34.8 15.4 12.6 14.6 21.4 16.2
Per cent 100.0 100.0 100.0 100.0 100.0 100.0
N= 69 657 231 89 56 1102*
*Missing observations=48 
We looked to see if there was a difference between the sexes on the frequency of use of their 
primary drug. A significant difference (p<.000) did appear between males and females on 
frequency of use. 
Table 4.17 – Frequency of Use of Primary Drug by Sex 
MALES TOTAL FREQUENCY OF USE 
IN PAST MONTH  per cent  
Drug free 9.8 10.8 9.9
Less than once weekly 4.1 10.3
Once weekly 3.4 3.8 3.5
Twice weekly 16.2 15.6
Daily 55.2 44.3 53.5
Twice or more daily 11.2 18.4 12.4
Per cent 100.0 100.0 100.0
N= 943 185
*Missing observations=22 
Chi-sq=22.78776 with 5df. p<.000 
FEMALE 
5.1
12.4
1128*
AGE 
Turning to age now and looking at duration and frequency of use of primary drug, it was to be 
expected that there would be significant differences between the age groups and the duration of 
use and this indeed was the case (p<.000). The older the client the more likely he or she had been 
misusing for a longer period. 
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Table 4.18 – Duration of Use of Primary Drug by Age 
<15 15-19 20-24 25-29 30-34 35+ TOTAL DURATION 
   per cent    
<1 year 29.7 6.5 5.2 1.9 – 6.2
1-2 years 62.2 77.6 47.7 32.4 29.4 59.7
2.7 24.8 18.5 17.6 21.0
5-9 years 5.4 2.1 13.2 15.2 14.8 23.5 8.1
10 years+ – 0.4 0.8 25.7 29.4 5.1
Per cent 100.0 100.0 100.0 100.0 100.0 100.0 100.0
N= 37 527 365 105 54 17 1105*
*Missing observations=45 
Chi-sq=440.35213 with 20df. p<.000 
 
Table 4.18A – Age by Duration of Use of Primary Drug 
<1yr  1-2yrs 3-4yrs 5-9yrs 10yrs+ TOTAL AGE 
  per cent    
<15 years 16.2 3.5 0.4 2.2 – 3.3
15-19 years 50.0 30.6 12.4 3.6 47.7
20-24 years 27.9 26.4 52.2 53.9 5.4 33.0
25-29 years 2.9 5.2 18.0 48.2 9.5
30-34 years 2.9 2.3 4.3 9.0 33.9 4.9
35 years + – 0.8 1.3 4.5 8.9 1.5
Per cent 100.0 100.0 100.0 100.0 100.0 100.0
N= 68 660 232 89 56 1105*
*Missing observations=45 
3.7
27.8
3-4 years 13.5 33.2
35.2
62.0
11.2
As regards frequency of use by age when we saw that there were differences between the duration 
of use of primary drug by age, it was to be expected that the frequency of use would also differ 
significantly by age. This was indeed the case, although the greatest differences occurred between 
the year olds and the other age groups – in that over 50 per cent of the under 15s were either 
drug-free or used less than once weekly, in comparison with 15 per cent overall. 
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Table 4.19 – Frequency of Use of Primary Drug by Age 
<15 15-19 20-24 25-29 30-34 35+ TOTALFREQUENCY OF USE 
IN PAST MONTH    per cent    
Drug free 17.9 8.5 11.3 6.7 12.3 15.8 
Less than once weekly 33.3 4.6 2.4 7.7 5.3 - 5.1
Once weekly 15.4 4.8 1.6 - 5.3 3.5
23.1 19.8 13.2 7.7 1.8 15.8 15.6
Daily 7.7 54.8 58.1 45.2 57.9 52.6 53.5
Twice or more daily 2.6 7.4 31.7 22.8 10.6 12.3
Per cent 100.0 100.0 100.0 100.0 100.0 100.0
N= 39 540 372 104 57 1131*
*Missing observations=19 
Chi-sq=190.32163 with 25df.p<.000 
9.9
1.0
Twice weekly 
13.4
100.0
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FREQUENCY OF USE BY ROUTE OF ADMINISTRATION OF PRIMARY DRUG 
The route of administration was significantly related to the frequency of use of the primary drug 
of misuse in that injectors were more likely to be misusing more frequently than any other group 
– more than eight out of ten misusing daily or more often. 
Table 4.20 – Frequency of Use by Route of Administration of Primary Drug 
INJECT SMOKE EAT/DRINK SNIFF TOTAL FREQUENCY OF USE 
IN PAST MONTH   per cent   
Drug Free 4.9 12.3 18.5 37.5 
Less than once weekly 5.1
Once weekly 0.2 5.7 8.2 12.5 3.5
Twice weekly 9.8 20.0 24.7 12.5 15.7
Daily 43.6 36.3 25.0 53.4
Twice or more daily 16.9 9.8 4.8 – 12.3
Per cent 100.0 100.0 100.0 100.0 100.0
N= 533 440 146 16 1135*
“Missing observations=15 
Chi-sq=185.06504 with 15df. p<.000 
10.0
1.3 8.6 7.5 12.5 
67.0
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ROUTE OF ADMINISTRATION OF PRIMARY DRUG BY PRIMARY DRUG 
The route of administration of the primary drug follows predictable lines with the majority of 
opiate/opioid users injecting and an even greater majority of cannabis users smoking. 
Table 4.21 – Route of Administration of Primary Drug by Primary Drug 
ROUTE OF 
ADMINISTRATION 
OP/OP. HYP/SED HALLUC VOLIN CANNAB OTHER 
    per cent    
Inject 62.4 – – – – – 
Smoke 29.3 – 15.4 98.9 8.3 38.6
Eat/Drink 8.1 100.0 92.5 0.5 66.7 13.2
Sniff 0.2 – 1.5 84.6 – 25.0 1.5
Per cent 100.0 100.0 100.0 100.0 100.0 100.0
N= 854 11 67 13 187 12 1144*
*Missing observations=6 
TOTAL 
46.7
6.0
–
100.0
ROUTE OF ADMINISTRATION OF PRIMARY DRUG BY SEX 
Significant differences were observed between males and females in the route of administration 
of their primary drug (p<.003). Females were less likely to inject but more likely to smoke their 
primary drug than were males. 
Table 4.22 - Route of Administration of Primary Drug by Sex 
MALES FEMALES TOTAL ROUTE OF ADMINISTRATION 
 per cent  
Inject 49.0 34.8 46.7
Smoke 37.4 44.9 38.6
Eat/Drink 12.2 18.2 13.2
Sniff 1.4 2.1 1.5
Per cent 100.0 100.0
N= . 949 187 1136*
*Missing observations=14 
Chi-sq=13.88837 with 3dt. p<.003 
100.0
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ROUTE OF ADMINISTRATION OF PRIMARY DRUG BY AGE 
Also in Chapters 2 and 3 the dramatic difference between the proportion in the under 15s who 
inject (3 per cent) and the proportion in the 15-19 year olds who do so (45 per cent) is 
remarkable. The under 15s are most likely to smoke (58 per cent). 
Table 4.23 – Route of Administration of Primary Drug by Age 
<15 15-19 20-24 25-29 30-34 35+ TOTAL ROUTE OF 
ADMINISTRATION    per cent    
Inject 2.5 44.9 52.4 54.7 49.1 31.6 46.8
Smoke 57.5 40.3 35.0 37.7 33.3 42.1 38.6
Eat/Drink 20.0 14.2 12.0 6.6 14.0 26.3 13.2
Sniff 20.0 0.6 0.5 0.9 3.5 – 1.4
Per cent 100.0 100.0 100.0 100.0 100.0 100.0 100.0
N= 40 543 374 106 57 19 1139*
*Missing observations = 11 
Chi-sq=141.67296 with 15df. p<.000 
Table 4.23A – Age by Route of Administration of Primary Drug 
INJECT SMOKE EAT/DRINK SNIFF TOTAL AGE 
  
<15 years 0.2 5.2 5.3 50.0 3.5
15-19 years 45.8 49.8 51.3 18.8 47.7
20-24 years 36.8 29.8 30.0 12.5 32.8
25-29 years 10.9 9.1 4.7 6.3 9.3
30-34 years 4.3 5.3 12.5 5.0
35 years + 1.1 1.8 3.3 – 1.7
Per cent 100.0 100.0 100.0 100.0 100.0
N= 440 150 16 1139*
*Missing observations=11 
 
  per cent 
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SECTION (c) – FACETS OF INJECTING AND NEEDLE-SHARING PRACTICES. 
CLIENTS WHO HAD EVER INJECTED 
The group, clients who had ever injected, will be considered now. Of those who had ever injected 
their primary drug (that is 53 per cent or 596 persons) the following socio-demographic 
characteristics were noted. 
SEX 
Where sex was concerned, of those first contact females who had ever injected proportionately 
more were currently injecting than were males (70 per cent males 78 per cent females). However 
if we look back at the proportions of males and females in the total population under study and 
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check what proportion of each sex were currently injecting, we see that the proportions are 
similar – 71 per cent of the males were currently injecting and 71 per cent of the females. 
Table 4.24 – Currently Injecting by Sex 
FEMALES TOTAL CURRENTLY INJECTING 
 per cent  
Yes 69.6 77.8 70.7
No 22.2 29.3
Per cent 100.0 100.0 100.0
N= 507 81 588*
*Missing observations=8. 
MALES 
30.4
CURRENTLY INJECTING BY AGE 
Only one under 15 year old had ever injected but was currently injecting. Of this group who had 
ever injected in 1994 the 15-19 year olds were as likely to be currently injecting as the older age 
groups. 
Table 4.25 – Currently Injecting by Age 
<15 15-19 20-24 25.29 30-34 35+ CURRENTLY INJECTING 
   per cent    
Yes 100.0 70.6 67.9 81.5 69.4 50.0 70.6
No – 29.4 32.1 18.5 30.6 50.0 29.4
Per cent 100.0 100.0 100.0 100.0 100.0 100.0 100.0
N= 1 265 218 65 36 6 591*
*Missing observations=5 
TOTAL 
CURRENTLY SHARING INJECTING EQUIPMENT 
As in the earlier chapters, we separated the group who were currently injecting to see the 
characteristics of those who were currently sharing injecting equipment. The first characteristic 
we looked at was sex of client by whether currently sharing or not. From this we noted that 
females were more likely to be sharing equipment than males – a not unexpected finding given 
that a proportionately higher number of females are living with a drug-using partner. 
Table 4.26 – Currently Sharing by Sex 
MALES FEMALES TOTAL CURRENTLY SHARING 
 per cent 
Yes 7.7 23.3 9.8
No 92.3 76.7 90.2
Per cent 100.0 100.0
N= 479 73
*Missing observations=44. 
 
100.0
552*
 58 
We then looked at the ages of those clients who were currently sharing injecting equipment. Of 
those who are currently sharing, the age group with the highest proportion of those sharing was 
the 30-34 year olds, as Table 4.26 shows. 
Table 4.27 – Currently Sharing by Age 
15-19 25.29 30-34 35+ TOTAL CURRENTLY SHARING 
   per cent    
Yes – 8.7 10.2 8.6 18.2 – 9.7
100.0 91.3 89.8 91.4 81.8 100.0 90.3
No= 1 252 206 58 33 6 556*
*Missing observations=40 
<15 20-24 
No 
MAIN POINTS ARISING 
The proportion of clients who were teenagers in this group is 51 per cent and most of those are in 
the 15-19 year old group – 47 per cent. If we extend this further to the under 25s the proportion 
rises to 84 per cent of the clients. The females in this first treatment group were also less likely to 
be living with their family of origin as was the case of the other two groups (Chapters 2 and 3). A 
smaller proportion of females were unemployed and there was a higher proportion employed or 
students than were males. However, the differences are not significant. 
Three-quarters of the clients cited an opiate/opioid as their primary drug of misuse and where 
numbers justified comment, cannabis was the drug with the longest duration of use. The 
differences between the behaviour of the under 15s and the 15-19 year olds in frequency of drug 
misuse is still a feature – the frequency jumps from 10 per cent of under 15s using daily or more 
often to 62 per cent of the 15-19 year olds with the same frequency of misuse. Those who 
injected their primary drug were the most frequent misusers. 
As with the other groups, of those clients who had ever injected – 53 per cent – females were 
proportionately more likely to be currently injecting than were males and also more likely to be 
currently sharing. 
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CHAPTER 5 
Graphic Data 
In this chapter we will first display the main variables in graphic form for Total Treatment clients 
and then contrast the Census and First Contact groups. The first set of pie charts in the 
comparative section shows that as regards gender, the proportion of males vis-a-vis females for 
1994 was higher in the First Contact group. 
Higher proportions of the Census clients (41 per cent) had left school prior to the official school 
leaving age than had the First Contact clients (26 per cent). 
Clients in the First Contact group were substantially younger than those in the Census group, for 
instance, 84 per cent were aged under 25 in 1994 in contrast with 37 per cent in the Census group. 
Similar proportions of clients were unemployed in the two groups in 1994. As the pie chart 
shows, in 1994 82 per cent of First Contact clients were unemployed and 80 per cent of Census 
clients. 
In the Area of Residence chart fairly similar proportions in each group came from the Inner City 
both North Inner City and South Inner City (First Contact group 27 per cent and Census group 30 
per cent). 
Although the proportions of clients in the First Contact group who came for treatment with an 
opiate as their primary drug were a great deal smaller than for the Census group it was still three 
quarters of the clients. The proportion for the Census group was 88 per cent. 
Where injecting was the route of administration of primary drug, as in previous years, the 
difference between the two groups in 1994 was very pronounced – 47 per cent of First Contact 
clients and 77 per cent of Census clients. 
When we compare the ages at which primary drug was first used, there is a difference between 
the two groups in that a higher proportion of First Contact clients were aged between 15 and 19 
years old than in the Census group. Where frequency of use of primary drug is concerned fairly 
similar proportions of clients used daily or more often. A slightly higher proportion of clients 
were drug-free in the Census group. 
As was to be expected the durations of use of primary drug were quite different for the Census 
and First Contact groups. Clients in the Census group had a far longer duration of use than had 
clients in the First Contact group. 
Where a secondary drug was recorded, in 1994 a higher proportion of Census clients than First 
Contact clients used no secondary drug. For the First Treatment clients, hallucinogens were noted 
in nine per cent of cases in 1994, whereas three per cent was the record of use of this category of 
drugs for Census clients. 
The proportions of clients who had ever injected in the two groups were also quite different. For 
1994 the proportions were 52 per cent of First Contact clients; 84 per of Census clients. 
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Of those clients who had ever injected the proportion of those First Contact clients in the 15-19 
year old age group was substantially higher than the proportion in the same age group for the 
Census clients – 74 per cent First Contact; 55 per cent Census. 
Currently injecting figures showed that the First Contact group were slightly more likely to be 
injecting in 1994 than the Census group – 70 per cent in contrast with 68 per cent for the Census 
group. However, Census group clients were twice as likely to have been sharing injecting 
equipment than were First Contact clients (20 per cent Census in contrast with 10 per cent First 
Contact). 
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CHAPTER 6 
Concluding Remarks 
This Report on treated drug misuse in the Greater Dublin Area in the year 1994 used data 
returned by the treatment centres. These data then relate to those problem drug users who present 
for treatment rather than all those who have drug problems, or indeed all those who use drugs. 
The results of the analysis confirm most of what is already known about problem drug users who 
present for treatment. 
There was no change in the proportion of clients who lived in the inner city – 31 per cent in 1993 
and 30 per cent in 1994. As in previous years, clients were characterised by levels of 
unemployment and low education far in excess of those for the population in general. 
As would be expected, opiates remained the drugs for which most of the clients sought treatment. 
Again the proportion in 1994 had increased over that of previous years now reaching 82 per cent 
of the total treatment clients. Isolating the younger First Contact group, while they would have a 
somewhat smaller proportion of problem opiate users than the total treated population, they still 
showed a proportion of three-quarters of opiate use as their primary drug. The proportion of those 
injecting their primary drug in the First Contact group was 47 per cent in 1994. 
Of all the clients who received treatment, seventy per cent of the 1994 clients had injected their 
primary drug at some stage in the past. Of those, 71 per cent were currently injecting. Of those 
who had ever shared – 59 per cent of the total treatment clients – the proportion of those who 
were currently sharing in this group for 1994 was 17 per cent. Again isolating the First Contact 
group, whom it will be remembered include the younger misusers, the comparative proportions 
for that group for those who had ever injected were 51 per cent and of that group, the proportion 
who were currently injecting was 71 per cent. Of those clients who has ever shared – 45 per cent 
of first treatment clients – 10 per cent were currently sharing injecting equipment. 
On the use of specific types of drugs, the rise is chiefly in the use of opiates (mainly heroin and 
morphine sulphate tablets) and here the increase in the number of teenagers using opiates would 
cause concern. Sixty-eight per cent of all teenagers coming for treatment for the first time in 1994 
had been misusing opiates. Also regarding this younger group of clients coming for treatment for 
the first time, a high proportion were using cannabis (21 per cent).A proportion of 7.5 per cent 
were coming for treatment for misuse of hallucinogens. As we pointed out last year, ecstasy is a 
fairly recent arrival on the market and has become associated with socialising. It therefore may 
have more appeal than other drugs to the younger group. Among the very young clients (under 
15s), there was a sub-group of users of volatile inhalants but the drug most likely to be used by 
these clients was cannabis (42 per cent). It must be emphasised that the number of clients who 
were under 15 and were receiving treatment was very small. Nevertheless the situation of these 
young people must give grounds for worry. One other particularly disturbing finding in relation to 
teenagers was that 71 per cent of those who had ever injected in the 15-19 year age group were 
currently injecting in 1994. 
As in previous years the most probable profile of the problem drug user who has come to a 
treatment centre would be that of a young, poorly educated, unemployed male, living in a 
deprived city area and misusing heroin. We found teenagers to be a particularly at-risk group with 
a disturbing number of them injecting heroin. Since Department of Health records show  
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that in 1994 almost half (43 per cent) of those who test positive for HIV were intravenous drug 
users, the importance of targeting this group of very young drug users with prevention and 
education programmes hardly needs to be stressed. While the schools’ programmes may reach a 
substantial number of young people, these programmes may be inadequate to reach the group 
who have already left school before the official school-leaving age. One-third of the total number 
of clients treated in 1994 would be in this group of early school-leavers and indeed if we include 
those leaving at 15 years old the proportion approaches two-thirds. 
There were significant differences between the characteristics of the male and female clients. For 
instance, male clients were more likely to be still living with their families of origin. Another 
difference between the sexes was that proportionately more female clients were living with a 
drug-using partner than were male clients. What may or may not have followed from that 
particular situation was that females were proportionately more likely to be sharing injecting 
equipment than males. ‘Sharing’ is, however, a problematic concept as drug users may define it 
differently. For instance, some would not regard sharing injecting equipment with a partner as 
sharing. Often only when the person with whom they share needles is outside of their circle 
would they define that as ‘sharing’. 
There was a continuing rise in the numbers attending the treatment centres for all the groups of 
clients involved. This may be a reflection of an expansion of the services available. As we 
pointed out in our last Report services were developed by the Eastern Health Board with the 
opening of the three satellite clinics and there is continuing development of services. The number 
of first contact clients or incidence is a good indicator of increasing or decreasing numbers 
coming into treatment and this number has substantially increased – from 859 in 1993 to 1150 in 
1994. However, it is not possible to know whether or not these figures reflect a rise in drug 
misuse in the general population. 
It is relevant here to refer to the present focus of public and governmental attention on the 
problem of drug misuse. Mr Austin Currie, Minister for State at the Department of Health has 
commented that there are approximately 800 people on the waiting list for treatment and has 
stressed the need for the opening of new treatment centres to cater for the needs of these drug 
misusers. In any compilation or estimation of numbers of drug misusers in Dublin, this figure has 
to be taken into consideration. As stressed at the opening of this Report, the figures we are 
analysing are of those persons who are already being treated for drug misuse. 
We have referred on a number of occasions throughout the report to our intention of producing a 
five-year report in 1995 covering the years 1990 to 1994 to examine trends in regard to various 
socio-demographic characteristics, the history and practices associated with drug misuse and the 
duration of misuse. The data are, of course, service dependent so the picture they provide of the 
extent and nature of drug problems will be influenced by the drug service provision. Whether this 
provision accounts totally for the increasing numbers appearing in our Reports is a question 
needing further investigation. 
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APPENDIX A 
Frequency Tables 1994 
NUMBERS 
 TOTAL TREATMENT CENSUS FIRST CONTACT 
Table Al 
Type of Contact 
new client 1780 178 1150
old client 1171 549 –
not known 27 1 –
Table A2 
Ever Previously Treated 
never 1269 119 1150
previously treated 1678 604 –
not known 31 5 –
Table A3 
In Contact with Other Centres 
no 2101 483 1150
yes 762 192 –
not known 115 53 –
Table A4 
Secondary Drug of Misuse 
Opiates/Opioids 949 251 410
Stimulants 65 10 25
Hypnotics/Sedatives 541 181 124
Hallucinogens 187 23 103
Volatile Inhalants 10 2 8
Cannabis 518 70 221
Alcohol 120 34 48
Other 2 – 1
No secondary drug 579 155 207
Not known 7 2 3
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 NUMBERS 
 TOTAL TREATMENT CENSUS FIRST CONTACT 
Age First Used 
Under 15 years 360 94 144
15-19 years 1244 232 617
20-24 years 374 121 79
25 years + 178 67 30
no secondary drug 579 155 207
not known 243 59 73
Table A6 
drug free 264 65
less than weekly 170 31 69
once weekly 183 39
twice weekly 483 83 255
daily 797 311
twice or more daily 336 152 51
no secondary drug 579 155 207
not known 166 28 59
Table A7 
Route of Administration 
inject 492 177 144
smoke 533 71 223
eat/drink 1226 292 528
sniff 39 6 17
no secondary drug 579 155 207
not known 109 27 31
Table A8 
Duration in Years 
<1 year 71
124 456
3-4 years 392 77 165
5-9 years 464 128 128
10 years + 399 158 67
no secondary drug 579 155 207
not known 292 78 87
Table A5 
Frequency in Past Month 
101
97
175
8 40
1-2 years 781
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APPENDIX B 
Population of the Greater Dublin Area 1991 
AGE AND SEX 
NUMBER AND PERCENTAGES 
 TOTAL CENSUS FIRST 
Male Female Total 
112769 106825 219594 
48.6 100.0 
Under 15 
25.8 22.4 24.0 
43446 43882 87328 
49.8 50.2 100.0 
15-19 
9.9 9.2 9.5 
4323 46168 89400 
48.4 51.6 100.0 
20–24 
9.9 9.7 9.8 
36418 40130 76548 
47.6 52.4 100.0 
25–29 
8.3 8.4 8.4 
32927 35454 68381 
48.2 51.8 100.0 
30–34 
7.5 7.4 7.5 
29236 31931 61167 
47.8 52.2 100.0 
35–39 
6.7 6.7 6.7 
27397 29154 56551 
48.4 51.6 100.0 
40–44 
6.3 6.1 6.2 
112364 144183 256547 
43.8 56.2 100.0 
45+ 
25.7 30.2 28.0 
All ages 437789 477727 915516 
Sex percentage 47.8 52.2 100.0 
Column Total 100.0 100.0 100.0 
Source: Ireland, Census of Population 1991,Central Statistics Office 
51.4 
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APPENDIX C 
Dublin Drug Reporting System 
TREATMENT CENTRES 
The Drug Treatment Centre Board 
− A statutory out-patient counselling, prescribing (methadone) and detoxification service, 
with 10 beds in Beaumont Hospital. 
Coolmine Therapeutic Community 
− A voluntary non-prescribing agency providing counselling and support at induction, day 
programme, residential and after care level. 
The Rutland Centre 
− A voluntary non-prescribing agency providing counselling and therapy at residential and 
day care level. 
The Ana Liffey Drug Project 
− A voluntary non-prescribing street agency offering counselling and support at day care 
level. 
Addiction Counsellors 
− A statutory non-prescribing service operated in the Dublin Community Care areas by eight 
professional workers from various health centres offering counselling and support at day 
care level. 
Ballymun Youth Action Project 
− A voluntary non-prescribing community based agency offering individual counselling, 
group work, family counselling and a range of social activities. 
General Practitioner 
− A non-prescribing, counselling and support service offered by a general practitioner. 
Benzodiazepines have occasionally been used to detoxify patients. 
St. Patrick’s Hospital 
− A service offered by psychiatrists in a private facility at in- or out-patient level. 
St. John of God Hospital 
− A service offered by psychiatrists in a private facility at in- or out-patient level. 
Mountjoy Prison 
− A detoxification, counselling and support service. 
St. Patrick’s Institution 
− A detoxification, counselling and support service. 
Arbour Hill Prison 
− A detoxification, counselling and support service. 
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Probation Service, Smithfield 
− A statutory counselling and support service for clients on probation. 
Talbot Day Centre 
− A statutory community-based programme for drug free youth providing remedial 
education, individual and group counselling. Group therapy is also available for family 
members. 
Mater Dei Counselling Centre 
− A voluntary specialised counselling unit for adolescents, providing out-patient services, 
such as individual counselling, family therapy and drama group. 
Ushers Island Clinic and Day Centre 
− A statutory agency providing assessment and treatment for disturbed adolescents on an 
out-patient basis. 
Wheatfield Prison 
− A detoxification, counselling and support service. 
Candle Community Trust 
− A community based centre for drug free young men providing support and counselling, 
personal development and training workshop facilities. 
Merchant’s Quay Project 
− A voluntary service providing counselling and advice to drug users affected by HIV and 
also referral to other agencies. 
Baggot Street Clinic 
− A statutory service offering harm minimisation, methadone maintenance, counselling, 
psychotherapy, detoxification programmes, residential treatment and rehabilitation 
programmes. 
Aisling Clinic 
− A statutory service offering harm minimisation, methadone maintenance, counselling, 
psychotherapy, detoxification programmes, residential treatment and rehabilitation 
programmes. 
City Clinic 
− A statutory service offering harm minimisation, methadone maintenance, counselling 
psychotherapy, detoxification programmes, residential treatment and rehabilitation 
programmes. 
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APPENDIX D 
Draft Core Data for Drug Treatment Reporting System 
POMPIDOU-EC PROJECT 
(Complete Boxes, write information and circle codes as appropriate) 
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INSTRUCTIONS FOR COMPLETION OF FORM 
(to be completed once for each client for the period under review) 
1. City/Health Board Area 
Enter appropriate code which will be provided. 
2. Treatment Centre 
Enter treatment centre code which will be provided. 
3. Client Number 
This should be a number which uniquely identifies the client. The first two digits will be 
the treatment centre code, the third digit the specialist code, where one exists within the 
centre, otherwise a zero will be used. The remaining five digits relate directly to the client 
and will be computer generated or supplied by the centre. 
4. Date 
This refers to the date on which the client makes contact with the centre. The first two 
digits refer to the day, the second two to the month and the last two to the year. Where day 
or month is represented by one digit, this digit should be entered in the second box of day 
or month, and a zero entered in the preceding box of day or month. 
5. Type of Contact with This Centre 
Circle the relevant code. New client is a client making a first contact with the treatment 
centre, old client is a client making a second or subsequent contact. It should be possible in 
all cases to distinguish between new and old clients and code accordingly, however code 9 
is provided when this information is not known. 
6. Ever Previously Treated 
Circle the relevant code. Never, refers to a client who has never has a drug-related 
treatment contact anywhere for drug misuse and is therefore making a first ever treatment 
contact. Previously treated, refers to a client who has already made contact whether with 
the centre for which information is being completed or who has had any other drug 
treatment contact elsewhere. This is a crucial question and it is essential that accurate 
information be obtained. (Please note that where a client is recorded as “never previously 
treated” he/she cannot be coded as “old client” in Q.5, nor as “currently in contact with 
other centres” in Q.7). 
7. Currently in Contact with other Centres – for a drug problem 
(a) Circle the relevant code. No, refers to a client who has not been in contact with 
another drug treatment centre(s) in the 30 days prior to the current contact. Yes, 
relates to a client who is or has been in contact with another centre(s) in the 30 days 
prior to the start of this treatment contact. It should be possible in all cases to 
establish whether a client is currently in contact with other centre(s) or not; however, 
code 9 is provided when this information is not known. 
(b) Where a current contact with other centre(s) has been ascertained and code 2 in the 
(a) part of the question is circled then the name(s) of the other centre(s) should be 
recorded. 
8. Sex 
Circle in the appropriate code. 
9. Age 
Record the client’s age in years at time of contact with the centre in the boxes provided. 
10. Living Status 
Circle the relevant code, and specify where necessary. Living status refers to current living 
status. Code 2, with family, refers to living with family of origin. Codes 4 and 5 relating to 
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partner – drug misuser/not drug misuser – may refer to a spouse or to a male/female 
partner lived with. 
11. Area of Residence 
Record the current area of residence by using the codes in the EIS street index. 
12. Ethnicity 
Circle relevant code and specify where necessary. 
13. Employment Status 
Record current employment status by circling the relevant code and specifying where 
necessary. 
14. Education 
(a) Record age in years when left full time education in boxes provided. 
(b) Record the highest educational level reached. Government sponsored work schemes 
are not regarded as educational schemes and therefore should not be recorded here. 
15. Problem Drug Use (refers to the month before presenting for treatment) Primary 
Record the drug name which the client alleges at the time of current contact is causing 
most problems and for which treatment is sought. 
Alcohol may not be recorded as a primary drug of misuse and clients whose primary drug 
of misuse is alcohol should be excluded from the system. 
Age First Used 
Record the relevant code for the drug recorded in this space provided from list supplied. 
Circle the relevant code. Injection refers to inserting a needle into a vein, muscle tissue, or 
under the skin. 
18. Ever Shared 
Secondary 
Where the client is misusing a second drug in addition to the primary one specified record 
the name. If none, write none. Alcohol may be recorded as a secondary drug. 
The age in years at which the client first misused the drug recorded. 
Frequency Past Month 
(prior to current treatment)  
Duration in Years 
Record the number of years for which the drug recorded has been actively misused. Six 
months to less than 12 months misuse should be recorded as one year. Less than six 
months misuse should be recorded as 0. 
16. Ever Injected 
(a) Circle the relevant code. 
Injection refers to inserting a needle into a vein, muscle tissue, or under the skin. 
(b) Record age in years when first injected. 
(Please note that if “no” is recorded for this question then Q.17, 18 and 19 are not 
applicable). 
17. Currently Injecting 
Circle the relevant code. 
19. Currently Sharing 
Circle the relevant code. 
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DRUG CLASSIFICATION 
1. Opiates and Opioids 
Buprenorphine 01 
Codeine (linctus) 02 
Dextromoramide 03 
Dextropropoxyphene 04 
Dihydrocodeine 05 
Dipipanone 06 
Heroin 07 
Methadone 08 
Morphine 09 
(including Morphine Sulphate Tablets –  
MST) 
Opium 10 
Pentazocine 11 
Pethidine 12 
Other Opiates/Opioids 88 
2. Stimulants 
Amphetamine 01 
Dexamphetamine 02 Butane 02
Methamphetamine 03 
Methylphenidate 04 
Other amphetamine like drugs 05 
Cocaine 06 
Crack 07 
Other cocaine forms 08 
3. Hypnotics and Sedatives 
Barbiturates 01 
Chlordiazepoxide 02 
Diazepam 03 
Flurazepam 04 
Lorazepam 05 
Oxazepam 06
Nitrazepam 07
Temazepam 08
Triazolam 09
Other minor tranquillizers 10
Major tranquillizers 11
Other hypnotics and sedatives 88
4. Hallucinogens 
Lysergic Acid Diethylamide 01
Amanita Muscaria 02
Psilocybin 03
Phencyclidine 04
MDMA (Ecstasy) 05
MDA 06
Other hallucinogens 88
5. Volatile Inhalants 
Glue 01
Other Solvents 03
Petrol 04
Nitrites 05
Other volatile inhalants 88
6. Cannabis 
Herbal 01
Resin 02
Oil 03
Other cannabis forms 88
7. Alcohol 
8. Other Drugs 
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Estimation of Rates for Treated Drug Misuse 
APPENDIX E 
The Report of treated drug misuse in the Greater Dublin Area for 1994 was based on information 
on three groups of clients – the total treatment contacts group; the Census of clients in treatment 
in December group and the first treatment contacts group. We now give the rates for treated drug 
misuse for each of these groups. Since the data presented in this Report related to cases and not to 
persons, some estimate must be obtained of the actual number of persons who entered treatment 
for their drug misuse in the Greater Dublin Area, in order to calculate the rates for the three 
groups involved (see previous reports for details of method of calculation) (1). 
It may be stated with confidence that the level of duplication of individuals reported to the Health 
Research Board from treatment centres was minimal, if existing at all. All report forms were 
checked individually before data entry and a check was again carried out at the end of year to 
detect any duplicate client numbering within centres. There is, however, a possibility of some 
double counting having arisen between centres. Because of this we included on the report form a 
question on whether or not the client was currently in contact with other centres for treatment of 
drug misuse and if the response was affirmative then the person completing the report form was 
asked to specify which centre or centres were involved. ‘Currently’ in this context referred to the 
thirty days prior to the client’s attendance for treatment. The response to the question and the 
specification of the other centre or centres where treatment was given enabled some estimate of 
the level of double counting to be made. 
Rates have been calculated for the 15-39 year age group. This age group accounted for 95 per 
cent of the drug users covered by this Report. 
The rates were calculated to be: 
Total Treatment Contacts 
Number 2702 
Rate 7.1 
Census of Clients in Treatment in December 
Number 657 
Rate 1.7 
First Treatment Contacts 
Number 1150 
Rate 3.0 
Rates were per ‘000 population aged between 15 and 39, based on 1991 Census of Population. 
The number of persons in that age group in the Census was 382,824. 
(1) O’Hare, A and M O’Brien (1992): Treated Drug, Misuse in the Greater Dublin Area, 7990. Dublin: The Health 
Research Board. 
 
